# Please go to the end to see rules of defining an atom

============================================================================================
      Definition begin
============================================================================================
--------------------------------------------------------------------------------------------
WILDATOM XX C N O S P
WILDATOM XA O S
WILDATOM XB N P
WILDATOM XC F Cl Br I
WILDATOM XD S P
WILDATOM XE N O
WILDATOM XH C H
-------------------------------------------------------------------------------------------- 
 f1  f2    f3  f4  f5  f6  f7  f8                               f9             f10 
-------------------------------------------------------------------------------------------- 
// Carbon types
// CY types
ATD  733    *   6   4   1   *   [RG3]                   (C[AR1])                                       &    ; all-atom C: CH, cyclopropyl benzene
ATD  711    *   6   4   2   *   [RG3]   &    ; CH2    C: cyclopropane
ATD  712    *   6   4   1   *   [RG3]   &    ; CHR    C: cyclopropane
ATD  713    *   6   4   0   *   [RG3]   &    ; CR2    C: cyclopropane

// CT_3 types
ATD  245    *   6   4   2   *   *                       (C4,N3(C3(O1)))                                &    ; C on N: tertiary  N-CH2R amide, Pro CD
ATD  296    *   6   4   2   *   [RG5]                   (C4,N4(C4(C3(O1))))                            &    ; C-delta in N-term PRO NH2+

// CT_2 types
ATD  906B   *   6   4   2   *   *                       (N3(H,H),C3(O1,N))                             &    ; CA in GLY-NH2 N-terminus
ATD  223B   *   6   4   2   *   *                       (N3,C3(O1,N))                                  &    ; Gly Calpha
ATD  225B   *   6   4   0   *   *                       (N,C4,C4,C3(O1))                               &    ; Aib Calpha.
ATD  246    *   6   4   1   *   [RG5]                   (C4,N3(C,C3(O1)),C3[NR](O1,N))                 &    ; C on N: tertiary  N-CHR2 amide, Pro CA
ATD  246    *   6   4   1   *   *                       (N3(C,C3[NR](O1)))                             &    ; C on N: tertiary  N-CHR2 amide, Pro CA
ATD  912B   *   6   4   1   *   *                       (N3(H,H),C3(O1,N))                             &    ; CA in NH2 N-terminus. All AA except GLY, PRO
ATD  224B   *   6   4   1   *   *                       (N3,C3(O1,N))                                  &    ; Calpha in most AA (except Gly,Pro,Aib)
ATD  285    *   6   4   1   *   [RG5]                   (C4,N3(C,C3(O1)),C3(O1,O))                     &    ; CA on C-terminal PRO
ATD  283    *   6   4   1   *   *                       (N3(C3(O1)),C3(O1,O))                          &    ; CA on C-terminal ALA,CYS,SER,THR,HIS,ASP,ASN
ATD  284    *   6   4   2   *   *                       (N3(C3(O1)),C3(O1,O))                          &    ; CA on C-terminal GLY
ATD  292B   *   6   4   2   *   *                       (N4,C3(O1,N))                                  &    ; CA in GLY-NH3+ N-term.
ATD  293B   *   6   4   1   *   *                       (N4,C3(O1,N))                                  &    ; CA in NH3+ N-term, All AA except GLY & PRO
ATD  295    *   6   4   1   *   [RG5]                   (C4,N3(H,C4),C3(O1,N))                         &    ; AA C-alpha on N-term PRO
ATD  298    *   6   4   2   *   *                       (N4,C3(O1,O))                                  &    ; AA C-alpha in Gly zwitterion
ATD  299    *   6   4   1   *   *                       (N4,C3(O1,O))                                  &    ; AA C-alpha in Ala zwitterion

// CT_4 types
ATD  160    *   6   4   2   *   *                       (C4(F,F,F),O(H))                               &    ; CH2 Trifluoroethanol

// C3 types
ATD  415    *   6   4   3   *   *                       (S[MI])                                        &    ; C  in  CH3S-  thiolate
ATD  418    *   6   4   3   *   *                       (O[MI])                                        &    ; C  in  CH3O-  alkoxide
ATD  425    *   6   4   3   *   *                       (N[MI])                                        &    ; C  in  CH3NH-
ATD  429    *   6   4   2   *   [MI]                    (C)                                            &    ; C2 in  CH3CH2- RCH2-

// C+ types
ATD  700    *   6   3   0   *   [PL]                    (C,C,C)                                        &    ; C+  in t-butyl+ B3LYP/6-31G*

// CO types
ATD  189    *   6   4   2   *   *                       (O(C),XE(C))                                   &    ; C(H2O2): acetal OCH2O
ATD  191    *   6   4   2   *   *                       (O(C),XA(H))                                   &    ; C(H2O2): hemiacetal OCH2OH
ATD  193    *   6   4   1   *   *                       (C,O(C),XE(C))                                 &    ; C(HCO2): acetal OCHRO
ATD  195    *   6   4   1   *   *                       (C,O(C),XA(H))                                 &    ; C(HCO2): hemiacetal OCHROH
ATD  197    *   6   4   0   *   *                       (C,C,O(C),XE(C))                               &    ; C(C2O2): acetal OCRRO
ATD  198    *   6   4   0   *   *                       (C,C,O(C),XA(H))                               &    ; C(C2O2): hemiacetal OCRROH

//  CT types
ATD  148    *   6   4   3   *   *                       (C[AR1])                                       &    ; C: CH3, toluene
ATD  725    *   6   4   0   *   *                       (C[AR1.AR2.AR3],F,F,F)                         &    ; CF3   trifluoromethylbenzene
ATD  149    *   6   4   2   *   *                       (C[AR1],C4)                                    &    ; C: CH2, ethyl benzene
ATD  152    *   6   4   2   *   *                       (Cl)                                           &    ; RCH2Cl in alkyl chlorides
ATD  443    *   6   4   *   *   *                       (O(P(O(XX),O,O)))                              &    ; C  in Me2PO4-, Me2PO4H dimethylphosphate
ATD  448    *   6   4   *   *   *                       (O(P(O,O,O)))                                  &    ; C  in MeOPO3--, MeOPO3H2   6-31+G* CHELPG
ATD  453    *   6   4   *   *   *                       (O(P(XX,O,O)))                                 &    ; C(O) MePO3Me-, MePO3HMe     methylphosphonate
ATD  455    *   6   4   *   *   *                       (P(O(XX)O,O))                                  &    ; C(P) MePO3Me-, MePO3HMe
ATD  458    *   6   4   *   *   *                       (O(P(XX,O,O)),XX[AR1.AR2.AR3])                 &    ; C(O) benzyl methylphosphonate
ATD  461    *   6   4   *   *   *                       (P(O(XX),O,O),XX[AR1.AR2.AR3])                 &    ; C(P)  methyl benzylphosphonate
ATD  173    *   6   4   2   *   *                       (C4(O2,C4(O2)),O2)                             &    ; C(H2OH): triols
ATD  174    *   6   4   1   *   *                       (O2,C4(O2),C4(O2))                             &    ; C(HROH): triols
ATD  174    *   6   4   1   *   *                       (O2,C4(O2,C4(O2)))                             &    ; C(HROH): triols
ATD  175    *   6   4   0   *   *                       (C4(O2,C4(O2)),O2)                             &    ; C(R2OH): triols
ATD  157    *   6   4   3   *   *                       (O2)                                           &    ; all-atom C: CH3 & CH2, alcohols
ATD  157    *   6   4   2   *   *                       (C4,O2)                                        &    ; all-atom C: CH3 & CH2, alcohols
ATD  158    *   6   4   1   *   *                       (C4,O2)                                        &    ; all-atom C: CH, alcohols
ATD  161    *   6   4   0   *   *                       (F,F,F,C(H,H,O(H)))                            &    ; CF3 Trifluoroethanol
ATD  159    *   6   4   0   *   *                       (O2(H))                                        &    ; all-atom C: C, alcohols
ATD  181    *   6   4   3   *   *                       (O(C(XH)))                                     &    ; C(H3OR): methyl ether
ATD  182    *   6   4   2   *   *                       (O(C(XH)))                                     &    ; C(H2OR): ethyl  ether
ATD  183    *   6   4   1   *   *                       (O(C(XH)))                                     &    ; C(HOR):  i-Pr   ether, allose
ATD  184    *   6   4   0   *   *                       (O(C(XH)))                                     &    ; C(OR):   t-Bu   ether
ATD  217    *   6   4   3   *   *                       (S2(H))                                        &    ; all-atom C: CH3, methanethiol
ATD  206    *   6   4   2   *   *                       (S2(H))                                        &    ; all-atom C: CH2, thiols
ATD  207    *   6   4   1   *   *                       (S2(H))                                        &    ; all-atom C: CH, thiols
ATD  208    *   6   4   0   *   *                       (S2(H))                                        &    ; all-atom C: C, thiols
ATD  213    *   6   4   3   *   *                       (S2(S2(C)))                                    &    ; all-atom C: CH3, disulfides
ATD  214    *   6   4   2   *   *                       (S2(S2(C)))                                    &    ; all-atom C: CH2, disulfides
ATD  215    *   6   4   1   *   *                       (S2(S2(C)))                                    &    ; all-atom C: CH, disulfides
ATD  216    *   6   4   0   *   *                       (S2(S2(C)))                                    &    ; all-atom C: C, disulfides
ATD  209    *   6   4   3   *   *                       (S2(C))                                        &    ; all-atom C: CH3, sulfides
ATD  210    *   6   4   2   *   *                       (S2(C))                                        &    ; all-atom C: CH2, sulfides
ATD  211    *   6   4   1   *   *                       (S2(C))                                        &    ; all-atom C: CH, sulfides
ATD  212    *   6   4   0   *   *                       (S2(C))                                        &    ; all-atom C: C, sulfides
ATD  218    *   6   4   2   *   *                       (C[AR1],O2)                                    &    ; C in CH2OH - benzyl alcohols
ATD  219    *   6   4   1   *   *                       (C[AR1],C,O2)                                  &    ; C in CHROH - benzyl alcohols
ATD  220    *   6   4   0   *   *                       (C[AR1],C,C,O2)                                &    ; C in CR2OH - benzyl alcohols
ATD  223    *   6   4   2   *   *                       (C,N3(H,H))                                    &    ; C in RCH2NH2. Use #223B for AA Calpha.
ATD  224    *   6   4   1   *   *                       (C,C,N3(H,H))                                  &    ; C in R2CHNH2. Use #224B for AA Calpha.
ATD  225    *   6   4   0   *   *                       (C,C,C,N3(H,H))                                &    ; C in R3CNH2. Use #225B for AA Calpha.
ATD  256    *   6   4   3   *   *                       (N3(C3(O1,XH),C3(O1,XH)))                      &    ; C in CH3  imide
ATD  257    *   6   4   2   *   *                       (N3(C3(O1,XH),C3(O1,XH)))                      &    ; C in RCH2 imide
ATD  258    *   6   4   1   *   *                       (N3(C3(O1,XH),C3(O1,XH)))                      &    ; C in R2CH imide
ATD  259    *   6   4   0   *   *                       (N3(C3(O1,XH),C3(O1,XH)))                      &    ; C in R3C  imide
ATD  229    *   6   4   1   *   *                       (N3(C3(O1)))                                   &    ; C on N: secondary N-CHR2 amide
ATD  230    *   6   4   0   *   *                       (N3(C3(O1)))                                   &    ; C on N: secondary N-CR3  amide
ATD  243    *   6   4   3   *   *                       (N3(C,C3(O1)))                                 &    ; C on N: tertiary  N-Me amide
ATD  242    *   6   4   3   *   *                       (N3(C3(O1)))                                   &    ; C on N: secondary N-Me amide
ATD  244    *   6   4   2   *   *                       (N3(C3(O1)))                                   &    ; C on N: secondary N-CH2R amide
ATD  273    *   6   4   3   *   *                       (C3(O1,O))                                     &    ; C: CH3, carboxylate ion
ATD  274    *   6   4   2   *   *                       (C3(O1,O))                                     &    ; C: CH2, carboxylate ion
ATD  275    *   6   4   1   *   *                       (C3(O1,O))                                     &    ; C: CH,  carboxylate ion
ATD  276    *   6   4   0   *   *                       (C3(O1,O))                                     &    ; C: C,   carboxylate ion
ATD  291    *   6   4   3   *   *                       (N4(H,H,H))                                    &    ; C in  CH3NH3+
ATD  292    *   6   4   2   *   *                       (N4(H,H,H))                                    &    ; C in  RCH2NH3+
ATD  293    *   6   4   1   *   *                       (N4(H,H,H))                                    &    ; C in  R2CHNH3+
ATD  294    *   6   4   0   *   *                       (N4(H,H,H))                                    &    ; C in  R3CNH3+
ATD  297    *   6   4   3   *   *                       (N4(H,H))                                      &    ; CT in  CH3NH2+R
ATD  305    *   6   4   3   *   *                       (N3(C3(N3,N)))                                 &    ; C: CH3, methylguanidinium
ATD  306    *   6   4   3   *   *                       (C(N3(C3(N3,N))))                              &    ; C: CH3, ethylguanidinium
ATD  748    *   6   4   2   *   *                       (C4(C4),N3(C3(N3,N2)))                         &    ; CD of neutral ARG
ATD  307    *   6   4   2   *   *                       (C4,N3(C3(N3,N)))                              &    ; C: CH2(D), ARG, ethylguanidinium
ATD  308    *   6   4   2   *   *                       (C4(N3(C3(N3,N))))                             &    ; C: CH2(G), ARG
ATD  331    *   6   4   3   *   *  (C[RG6,AR1.AR2.AR3](C[RG6](O[NR],N[RG6]),C3[RG6](N[RG6](C3[RG6](O[NR])))))          &    ; Thymine C-C5
ATD  371    *   6   4   *   *   *  (N[RG5,AR1.AR2.AR3](C[RG5](N2(C[RG5,AR1](C[AR1](O1,N[AR1])))),C[RG5,AR1](N2[AR1]))) &    ; 9-Me Adenine or Guanine C-N9
ATD  373    *   6   4   3   *   *  (N[RG6,AR1.AR2.AR3](C[RG6](O[NR],N[RG6]),C3[RG6](C3[RG6](C[RG6](O[NR],N[RG6])))))   &    ; 1-Me Uracil or Thymine C-N1
ATD  375    *   6   4   *   *   *         (N[RG6](C[RG6](O1,N2[RG6](C[RG6](N[NR]))),C[RG6](C[RG6])))   &    ; 1-Me Cytosine C-N1
ATD  391    *   6   4   3   *   *         (N[RG6](C[RG6](O1,N3[RG6](C[RG6](N[NR]))),C[RG6](C[RG6])))   &    ; 1-Me CytH+ C-N1
ATD  421    *   6   4   2   *   *                       (C2(N[MI]))                                    &    ; C1 in  CH2CN-  RCN-
ATD  431    *   6   4   3   *   *                       (C[MI](H,H))                                   &    ; C1 in  CH3CH2-
ATD  468    *   6   4   *   *   *                       (O[NR](C3(O1)))                                &    ; methoxy C in esters - see also #490-492
ATD  476    *   6   4   *   *   *                       (S(N3,O1,O1))                                  &    ; CH3 attached to S of sulfonamide
ATD  482    *   6   4   3   *   *                       (N3(S(O1,O1)))                                 &    ; alpha CH3-N of sulfonamide
ATD  484    *   6   4   2   *   *                       (N3(S(O1,O1)))                                 &    ; alpha CH2-N of sulfonamide. Use q=0.45 for CRH-N, q=0.65 for O=N-C-CH-N.
ATD  486    *   6   4   3   *   *                       (C4(N3(S(O1,O1))))                             &    ; beta CH3 of N-ethyl sulfonamide
ATD  490    *   6   4   2   *   *                       (O(S))                                         &    ; C(H2OS) ethyl ester
ATD  491    *   6   4   1   *   *                       (O(S))                                         &    ; C(HOS) i-pr ester
ATD  492    *   6   4   0   *   *                       (O(S))                                         &    ; C(OS) t-bu ester
ATD  498    *   6   4   3   *   *                       (S(O1,C))                                      &    ; CH3 all-atom C: sulfoxide
ATD  499    *   6   4   2   *   *                       (S(O1,C))                                      &    ; CH2 all-atom C: sulfoxide
ATD  505    *   6   4   2   *   *                       (C3[RG5,AR2](N(C3)))                           &    ; CB in His
ATD  515    *   6   4   1   *   *                       (C3[AR1.AR2.AR3],C4,C4)                        &    ; all-atom C: CH, isopropyl benzene
ATD  516    *   6   4   0   *   *                       (C3[AR1.AR2.AR3],C4,C4,C4)                     &    ; all-atom C: C,  t-butyl benzene
ATD  645    *   6   4   *   *   *    (C3[RG5,AR2](C[AR2,AR1](C[RG6](C[RG6](O[NR]))),C[RG5](N[RG5])))   &    ; C on C3 in serotonin
ATD  670    *   6   4   3   *   *    (C3[RG6,AR1.AR2.AR3](N[RG6](C3[RG6]),C3[RG6](C3[RG6](C3[RG6]))))  &    ; CH3, 2-methyl pyridine
ATD  671    *   6   4   2   *   *    (C3[RG6,AR1.AR2.AR3](N[RG6](C3[RG6]),C3[RG6](C3[RG6](C3[RG6]))))  &    ; CH2, 2-ethyl pyridine
ATD  672    *   6   4   3   *   *     (C3[RG6,AR1.AR2.AR3](N[RG6](N[RG6]),C3[RG6](C3[RG6](C3[RG6]))))  &    ; CH3, 3-methyl pyridazine
ATD  673    *   6   4   2   *   *     (C3[RG6,AR1.AR2.AR3](N[RG6](N[RG6]),C3[RG6](C3[RG6](C3[RG6]))))  &    ; CH2, 3-ethyl pyridazine
ATD  674    *   6   4   3   *   *          (C[RG6,AR1.AR2.AR3](N[RG6](C[RG6](N[RG6])),C[RG6](C[RG6]))) &    ; CH3, 4-methyl pyrimidine
ATD  675    *   6   4   2   *   *          (C[RG6,AR1.AR2.AR3](N[RG6](C[RG6](N[RG6])),C[RG6](C[RG6]))) &    ; CH2, 4-ethyl pyrimidine
ATD  676    *   6   4   3   *   *                      (C3[RG6,AR1.AR2.AR3](N[RG6]),C3[RG6](N[RG6]))   &    ; CH3, 2-methyl pyrazine
ATD  677    *   6   4   2   *   *                      (C3[RG6,AR1.AR2.AR3](N[RG6]),C3[RG6](N[RG6]))   &    ; CH2, 2-ethyl pyrazine
ATD  678    *   6   4   3   *   *          (C3[RG5,AR1.AR2.AR3],(C3[RG5](C3[RG5]),N3[RG5](C3[RG5])))   &    ; CH3, 2-methyl pyrrole
ATD  679    *   6   4   2   *   *          (C3[RG5,AR1.AR2.AR3],(C3[RG5](C3[RG5]),N3[RG5](C3[RG5])))   &    ; CH2, 2-ethyl pyrrole
ATD  680    *   6   4   3   *   *          (C3[RG5,AR1.AR2.AR3],(C3[RG5](C3[RG5]),XA2[RG5](C3[RG5])))  &    ; CH3, 2-methyl furan
ATD  681    *   6   4   2   *   *          (C3[RG5,AR1.AR2.AR3],(C3[RG5](C3[RG5]),XA2[RG5](C3[RG5])))  &    ; CH2, 2-ethyl furan
ATD  701    *   6   4   *   *   *                       (C[PL](C,C))                                   &    ; C  in t-butyl+ B3LYP/6-31G*
ATD  747    *   6   4   3   *   *                       (N3[NR](C(N3[NR],N2[NR])))                     &    ; CH3 in neutral MeGDN
ATD  755    *   6   4   3   *   *                       (C2(N1))                                       &    ; C of CH3 in CH3CN
ATD  756    *   6   4   2   *   *                       (C4,C2(N1))                                    &    ; C of CH2 in RCH2CN
ATD  757    *   6   4   1   *   *                       (C4,C4,C2(N1))                                 &    ; C of CH  in R2CHCN
ATD  758    *   6   4   0   *   *                       (C4,C4,C4,C2(N1))                              &    ; C of C   in R3CCN
ATD  762    *   6   4   3   *   *                       (N3(O,O))                                      &    ; CT-NO2 nitromethane
ATD  764    *   6   4   2   *   *                       (C4(H,H,H),N3(O,O))                            &    ; CT-NO2 nitroethane
ATD  765    *   6   4   1   *   *                       (C4(H,H,H),C4(H,H,H),N3(O,O))                  &    ; CT-NO2 2-nitropropane
ATD  766    *   6   4   0   *   *                       (C4(H,H,H),C4(H,H,H),C4(H,H,H),N3(O,O))        &    ; CT-NO2 2-methyl-2-nitropropane
ATD  774    *   6   4   2   *   [RG5]                   (C4[RG5](C4[NR],O[RG5](C3[RG5](O1))),O[RG5])   &    ; propylene carbonate C in CH2
ATD  775    *   6   4   1   *   [RG5]                   (C4[NR],C4[RG5](O[RG5]),O[RG5](C[RG5](O1)))    &    ; propylene carbonate C in CH
ATD  776    *   6   4   3   *   [NR]                    (C4[RG5](C4[RG5](O[RG5]),O[RG5](C[RG5](O1))))  &    ; propylene carbonate C in CH3
ATD  782    *   6   4   3   *   *                       (P[PL](C,C,C))                                 &    ; CH3PR3+ 6-31G* CHELPG
ATD  783    *   6   4   2   *   *                       (P[PL](C,C,C))                                 &    ; RCH2PR3+
ATD  903    *   6   4   3   *   *                       (N3(H,H))                                      &    ; CH3(N) primary   aliphatic amines, H(C) is #911
ATD  904    *   6   4   3   *   *                       (N3(H,C))                                      &    ; CH3(N) secondary aliphatic amines, H(C) is #911
ATD  905    *   6   4   3   *   *                       (N3(C,C))                                      &    ; CH3(N) tertiary  aliphatic amines, H(C) is #911
ATD  906    *   6   4   2   *   *                       (N3(H,H))                                      &    ; CH2(N) primary   aliphatic amines, H(C) is #911
ATD  907    *   6   4   2   *   *                       (N3(H,C))                                      &    ; CH2(N) secondary aliphatic amines, aziridine  C2,C3H
ATD  908    *   6   4   2   *   *                       (N3(C,C))                                      &    ; CH2(N) tertiary  aliphatic amines, H(C) is #911
ATD  912    *   6   4   1   *   *                       (C4,C4,N3(H,H))                                &    ; CH     primary isopropyl amine
ATD  913    *   6   4   0   *   *                       (C4,C4,C4,N3(H,H))                             &    ; C      primary t-butyl amine
ATD  914    *   6   4   1   *   *                       (C4,C4,N3(H,C))                                &    ; CH     secondary isopropyl amine
ATD  915    *   6   4   1   *   *                       (C4,C4,N3(C,C))                                &    ; CH     tertiary  isopropyl amine
ATD  942    *   6   4   3   *   *                       (N4(H,C,C))                                    &    ; C in  CH3NHR2+
ATD  943    *   6   4   2   *   *                       (N4(H,C,C))                                    &    ; C in  RCH2NHR2+
ATD  944    *   6   4   1   *   *                       (N4(H,C,C))                                    &    ; C in  R2CHNHR2+
ATD  945    *   6   4   0   *   *                       (N4(H,C,C))                                    &    ; C in  R3CNHR2+
ATD  951    *   6   4   2   *   *                       (N4(H,H,H),C3(O1,O))                           &    ; glycine zwit. 6-31G* CHELPG charges
ATD  957    *   6   4   3   *   *                       (F)                                            &    ; RCH2F in monoalkyl fluorides (tentative)
ATD  957    *   6   4   2   *   *                       (C,F)                                          &    ; RCH2F in monoalkyl fluorides (tentative)
ATD  959    *   6   4   1   *   *                       (C,C,F)                                        &    ; R2CHF in monoalkyl fluorides (tentative)
ATD  961    *   6   4   0   *   *                       (C(F,F),F,F,F)                                 &    ; CF3 perfluoroalkanes
ATD  962    *   6   4   0   *   *                       (C(F,F),C(F,F),F,F)                            &    ; CF2 perfluoroalkanes
ATD  963    *   6   4   0   *   *                       (C(F,F),C(F,F),C(F,F),F)                       &    ; CF perfluoroalkanes
ATD  960    *   6   4   0   *   *                       (C,C,C,F)                                      &    ; R3CF in monoalkyl fluorides (tentative)
ATD  964    *   6   4   0   *   *                       (F,F,F,F)                                      &    ; CF4
ATD  135    *   6   4   3   &    ; alkane CH3
ATD  136    *   6   4   2   &    ; alkane CH2
ATD  137    *   6   4   1   &    ; alkane CH
ATD  138    *   6   4   4   &    ; alkane CH4
ATD  139    *   6   4   0   &    ; alkane C

// C_2 types
ATD  232    *   6   3   1   *   [DB]                    (C[AR1.AR2.AR3],XA1)                           &    ; C: C=O in benzaldehyde,acetophenone (CH)
ATD  232    *   6   3   0   *   [DB]                    (C[AR1.AR2.AR3],XA1,C4)                        &    ; C: C=O in benzaldehyde,acetophenone (CH)
ATD  233    *   6   3   3   *   *                       (C3(C[AR1.AR2.AR3],XA1))                       &    ; C: C=O in acetophenone (CMe)
ATD  277    *   6   3   1   *   [DB]                    (C,XA1)                                        &    ; C: aldehyde - for C-alpha use #135-#139
ATD  280    *   6   3   0   *   [DB]                    (C,C,XA1)                                      &    ; C: ketone - for C-alpha use #135-#139
ATD  465    *   6   3   *   *   [DB]                    (XA1,XA2(C))                                   &    ; C: esters - for R on C=O, use #280-#282

// C_3 types
ATD  271    *   6   3   *   *   *                       (O1,O1)                                        &    ; C in COO- carboxylate

// C types
ATD  320    *   6   3   *   *   [RG6,AR1.AR2.AR3] (O[NR],N[RG6](C[RG6](C[RG6])),N[RG6](C[RG6](O[NR])))  &    ; Uracil & Thymine C2
ATD  322    *   6   3   *   *   [RG6,AR1.AR2.AR3] (O[NR],N[RG6](C[RG6](O[NR],N[RG6])),(C[RG6](C[RG6]))) &    ; Uracil & Thymine C4
ATD  334    *   6   3   *   *   [RG6,AR1.AR2.AR3]   (O1,N2[RG6](C(N[NR],C[RG6])),N[RG6](C[RG6]))       &    ; Cytosine C2
ATD  334    *   6   3   *   *   [RG6,AR1.AR2.AR3]   (O1,N2[RG6](C(H,C[RG6])),N[RG6](C[RG6]))           &    ; zebulariine C2
ATD  366    *   6   3   *   *   [RG6,AR1.AR2.AR3] (O[NR],C[RG5,RG6](N[RG5](C3(H,N[RG5]))),N[RG6](C3(N[NR],N[RG6])))        &    ; Guanine C6
ATD  378    *   6   3   *   *   [RG6,AR1.AR2.AR3]   (O1,N3[RG6](C(N[NR],C[RG6])),N[RG6](C[RG6]))       &    ; CytH+ C2
ATD  772    *   6   3   *   *   [RG5]                   (XA1,XA[RG5](C4[RG5](C4[NR],C4[RG5])),XA[RG5]) &    ; propylene carbonate C=O
ATD  231    *   6   3   *   *   *                       (C[AR1.AR2.AR3],C[AR1.AR2.AR3],XA1)            &    ; C: C=O in benzophenone
ATD  952    *   6   3   *   *   *                       (XA1,XA,C4(N4,H,H))                            &    ; glycine zwit. 6-31G* CHELPG charges
ATD  234    *   6   3   *   *   [DB]                    (C[AR1.AR2.AR3],XA1,N3)                        &    ; C: C=O in benzamide
ATD  252    *   6   3   *   *   *                       (XA1,N3(C3(XA1,C)))                            &    ; C(=O) in imide
ATD  252    *   6   3   *   *   *                       (XA1,N3(C3(XA1,H)))                            &    ; C(=O) in imide
ATD  267    *   6   3   0   *   *                       (C4,XA1,XA2(H))                                &    ; Co in CCOOH carboxylic acid
ATD  470    *   6   3   *   *   *                       (C[AR1.AR2.AR3],XA1,XA2)                       &    ; Co in benzoic acid
ATD  471    *   6   3   *   *   *                       (C[AR1.AR2.AR3],XA1,XA2(C))                    &    ; Co in methyl benzoate, aryl ester
ATD  247    *   6   3   0   *   *                       (O1,N3,N3)                                     &    ; C in O=C(NH2)2  Urea  Isr. J. Chem. 33, 323 (93)
ATD  235    *   6   3   1   *   [DB]                    (O1,N3)                                        &    ; C=O in amide, dmf, peptide bond
ATD  235    *   6   3   0   *   [DB]                    (O1,N3)                                        &    ; C=O in amide, dmf, peptide bond

// CN types
ATD  502    *   6   3   *   *   [RG5,RG6,AR1.AR2]       (C[RG5,RG6](C[RG5](C4[NR])),N[RG5],C[RG6])     &    ; CE2 C in Trp
ATD  594    *   6   3   *   *   [RG5,RG6,AR1.AR2]       (C[RG5,RG6](C[RG5]),N[RG5],C[RG6])             &    ; C8 in indole

// CB types
ATD  349    *   6   3   0   *   [RG5,RG6,AR1.AR2] (N3[RG5](C3(N2[RG5](C[RG5,RG6](C[RG6](N[NR],N[RG6]))))),N2[RG6](C3(N[RG6]))) &    ; Adenine C4
ATD  350    *   6   3   0   *   [RG5,RG6,AR1.AR2]   (C[RG6](N[NR],N[RG6](C3(N2(C[RG5,RG6](N3[RG5]))))),N2[RG5](C3(N3[RG5])))   &    ; Adenine C5
ATD  364    *   6   3   0   *   [RG5,RG6,AR1.AR2.AR3]   (N[RG6](C3(N[NR],N[RG6])),N[RG5](C3(H,N[RG5]))) &    ; Guanine C4
ATD  365    *   6   3   0   *   [RG5,RG6,AR1.AR2.AR3]   (N[RG5](C3(H,N[RG5])),C[RG6](O[NR]),C[RG5,RG6]) &    ; Guanine C5
ATD  501    *   6   3   0   *   [RG5,RG6,AR1.AR2]       (C[RG5,RG6](N[RG5]),C[RG6],C[RG5](C4))         &    ; CD2 C in Trp
ATD  595    *   6   3   0   *   [RG5,RG6,AR1.AR2]       (C[RG5,RG6](N[RG5]),C[RG6],C[RG5])             &    ; C9 in indole
ATD  623    *   6   3   0   *   [RG5,RG6,AR1.AR2]       (N[RG6](C3(N[RG6])),N[RG5](C3(N2)))            &    ; C4 in purine
ATD  624    *   6   3   0   *   [RG5,RG6,AR1.AR2]       (N[RG5](C3(N[RG5])),C[RG6],C[RG5,RG6])         &    ; C5 in purine

// CK types
ATD  353    *   6   3   *   *   [RG5,AR1.AR2.AR3] (N3[RG5](C[RG5,RG6](N2[RG6])),N2[RG5](C[RG5,RG6](C[RG6](XE,N[RG6])))) &    ; Adenine & Guanine C8
ATD  627    *   6   3   *   *   [RG5,AR1.AR2.AR3]       (N2(C[RG5,RG6](C[RG6])),N3)                    &    ; C8  in purine

// CR types
ATD  506    *   6   3   *   *   [RG5,AR2]               (N2(C3[RG5](C4[NR])),N3(H,C3[RG5]))            &    ; CE1 in HID, HIE
ATD  506    *   6   3   *   *   [RG5,AR2]               (N2(C3[RG5]),N3(H,C3[RG5](C4[NR])))            &    ; CE1 in HID, HIE
ATD  509    *   6   3   *   *   [RG5,AR2]               (N3(C3[RG5]),N3[RG5](C3[RG5](C4[NR])))         &    ; CE1 in HIP
ATD  558    *   6   3   *   *   [RG5,AR1.AR2.AR3]       (N[RG5](C3[RG5]),N3[RG5](C3[RG5]))             &    ; C2  in imidazole
ATD  572    *   6   3   *   *   [RG5,AR1.AR2.AR3]       (N[RG5](C3[RG5]),O[RG5](C3[RG5]))              &    ; C2  in oxazole
ATD  634    *   6   3   *   *   [RG5,AR1.AR2.AR3]       (N[RG5](C3[RG5]),S2[RG5](C3[RG5]))             &    ; C2  in thiazole
// CR    *   6   3   *   *   [RG5,AR1.AR2.AR3]        (N2,N3(H))              &

// CC    *   6   3   0   *   [RG5,AR1.AR2.AR3]        (C3,N3(C3,H))              &
// CC    *   6   3   0   *   [RG5,AR1.AR2.AR3]        (C3,N2(C3))              &

// CW types
ATD  508    *   6   3   0   *   [RG5,AR1.AR2.AR3]       (C4,C3,N3(C3,H))                               &    ; CG in HID, CD2 in HIE
ATD  508    *   6   3   1   *   [RG5,AR1.AR2.AR3]       (C3,N3(C3,H))                                  &    ; CG in HID, CD2 in HIE
ATD  514    *   6   3   *   *   [RG5,AR1.AR2.AR3]       (C3[RG5](C4,C[RG5,RG6]),N3[RG5])               &    ; CD1 in TRP
ATD  543    *   6   3   *   *   [RG5,AR1.AR2.AR3]       (C3[RG5](C3[RG5]),N3[RG5](C3[RG5]))            &    ; C2  in pyrrole
ATD  552    *   6   3   *   *   [RG5,AR1.AR2.AR3]       (C3[RG5],N3[RG5](N[RG5](C3[RG5])))             &    ; C5  in pyrazole
ATD  561    *   6   3   *   *   [RG5,AR1.AR2.AR3]       (C3[RG5](N[RG5]),N3[RG5](C3[RG5]))             &    ; C5  in imidazole
ATD  567    *   6   3   *   *   [RG5,AR1.AR2.AR3]       (C3[RG5](C3[RG5]),XA2[RG5](C3[RG5]))           &    ; C2  in furan
ATD  575    *   6   3   *   *   [RG5,AR1.AR2.AR3]       (C3[RG5](N[RG5]),O[RG5](C3[RG5]))              &    ; C5  in oxazole
ATD  583    *   6   3   *   *   [RG5,AR1.AR2.AR3]       (C3[RG5],O[RG5](N[RG5](C3[RG5])))              &    ; C5  in isoxazole
ATD  588    *   6   3   *   *   [RG5,AR1.AR2.AR3]       (C3[RG5](C[RG5,RG6]),N3[RG5])                  &    ; C2  in indole
ATD  637    *   6   3   *   *   [RG5,AR1.AR2.AR3]       (C3[RG5](N[RG5]),S2[RG5](C3[RG5]))             &    ; C5  in thiazole

// CV types
ATD  507    *   6   3   0   *   [RG5,AR1.AR2.AR3]       (C4,C3[RG5],N2[RG5](C3[RG5]))                  &    ; CD2 in HID, CG in HIE
ATD  507    *   6   3   *   *   [RG5,AR1.AR2.AR3]       (C3[RG5],N[RG5](C3[RG5]))                      &    ; CD2 in HID, CG in HIE
ATD  560    *   6   3   *   *   [RG5,AR1.AR2.AR3]       (C3[RG5](N3[RG5]),N[RG5](C3[RG5]))             &    ; C4  in imidazole
ATD  574    *   6   3   *   *   [RG5,AR1.AR2.AR3]       (C3[RG5](N3[RG5]),O[RG5](C3[RG5]))             &    ; C4  in oxazole
ATD  636    *   6   3   *   *   [RG5,AR1.AR2.AR3]       (C3[RG5](N3[RG5]),S2[RG5](C3[RG5]))            &    ; C4  in thiazole

// C* types
ATD  500    *   6   3   0   *   [RG5,AR1.AR2.AR3]       (C4,C3[RG5](N3(C[RG5,RG6])),C[RG5,RG6])        &    ; CG in Trp

// CQ types
ATD  347    *   6   3   *   *   [RG6,AR1]  (N2(C[AR2,AR1](N3[AR2])),N[AR1](C[AR1](N[NR],C[AR2,AR1](N2[AR2])))) &    ; Adenine C2
ATD  621    *   6   3   *   *   [RG6,AR1]  (N[RG6](C[RG5,RG6](N[RG5])),N[RG6](C3[RG6](C[RG5,RG6](N[RG5]))))    &    ; C2  in purine
ATD  531    *   6   3   *   *   [RG6,AR1.AR2.AR3]       (N[RG6](C3[RG6]),N[RG6](C3[RG6](C3[RG6])))     &    ; C2  in pyrimidine
ATD  642    *   6   3   *   *   [RG6,AR1.AR2.AR3]       (N2(C3[RG6]),N2(C3[RG6](N2[RG6])))             &    ; C   in 1,3,5-triazine

// CM types
ATD  227    *   6   3   *   *   [NR,DB]                 (C3,Cl)                                        &    ; chloroalkene C (ClH-C=)
ATD  141    *   6   3   0   *   [NR,DB]                 (C3,C,C)                                       &    ; alkene C (R2-C=)
ATD  143    *   6   3   2   *   [NR,DB]                 (C3)                                           &    ; alkene C (H2-C=)
ATD  142    *   6   3   1   *   [NR,DB]                 (C3,C)                                         &    ; alkene C (RH-C=)
ATD  323    *   6   3   *   *   [RG6,AR1.AR2.AR3] (C[RG6](O[NR],N[RG6]),C3[RG6](N[RG6](C[RG6](O[NR])))) &    ; Uracil & Thymine C5
ATD  324    *   6   3   *   *   [RG6,AR1.AR2.AR3]   (N[RG6](C(O[NR],N[RG6])),C3[RG6](C[RG6](O[NR])))   &    ; Uracil & Thymine C6
ATD  337    *   6   3   1   *   [RG6,AR1.AR2.AR3]   (C[RG6](N[NR],N2[RG6]),C[RG6](N[RG6](C[RG6](O1)))) &    ; Cytosine C5   Nucleotide base parameters:
ATD  338    *   6   3   1   *   [RG6,AR1.AR2.AR3]   (C[RG6](C[RG6](N[NR],N2[RG6])),N[RG6](C[RG6](O1))) &    ; Cytosine C6      JACS,113,2810(1991)
ATD  381    *   6   3   1   *   [RG6,AR1.AR2.AR3]   (C[RG6](N[NR],N3[RG6]),C[RG6](N[RG6](C[RG6](O1)))) &    ; CytH+ C5
ATD  382    *   6   3   1   *   [RG6,AR1.AR2.AR3]   (C[RG6](C[RG6](N[NR],N3[RG6])),N[RG6](C[RG6](O1))) &    ; CytH+ C6
ATD  518    *   6   3   0   *   [NR]                (C[DB'],O(C(XH)))                                  &    ; vinyl ether RCOR
ATD  517    *   6   3   *   *   [NR]                (C[DB'],O(C(XH)))                                  &    ; vinyl ether HCOR
//ATD  708    *   6   3   *   *           &    ; C in Cl..CH3..Cl- TS
// CM    *   6   3   *   *   [RG6,AR1.AR2.AR3]        (C3,C3(N3(C3(N3(C3))))) &
// CM    *   6   3   *   *   [RG6,AR1.AR2.AR3]        (C3,N3(C3(N2(C3(C3))))) &
// CM    *   6   3   *   *   [RG6,AR1.AR2.AR3]        (N3,C3(C3(N3(C3(N3))))) &
// CM    *   6   3   &

// CA types
ATD  166    *   6   3   0   *   [RG6,AR1.AR2.AR3]       (O2)                                           &    ; C(OH) phenol  Use with all
ATD  199    *   6   3   *   *   [RG6,AR1.AR2.AR3]       (O(C4))                                        &    ; C(O,Me): anisole
ATD  221    *   6   3   0   *   [RG6,AR1.AR2.AR3]       (C(H,H,O(H)))                                  &    ; C(CH2OH)   - benzyl alcohols
ATD  228    *   6   3   *   *   [RG6,AR1.AR2.AR3]       (S2(C4))                                       &    ; C(SMe)  thioanisole
ATD  260    *   6   3   0   *   [RG6,AR1.AR2.AR3]       (C2(N1))                                       &    ; C(CN)  benzonitrile
ATD  263    *   6   3   0   *   [RG6,AR1.AR2.AR3]       (Cl)                                           &    ; C(Cl)  chlorobenzene
ATD  266    *   6   3   *   *   [RG6,AR1]               (N3[NR](C3[NR](XA1,C4)))                       &    ; ipso C in N-phenylacetamide
ATD  312    *   6   3   0   *   [RG6,AR1.AR2.AR3] (N[NR],C3[RG6](C3[RG6]),N[RG6](C3[RG6](N[NR],C3[RG6]))) &    ; DAP C2
ATD  315    *   6   3   1   *   [RG6,AR1.AR2.AR3] (C3[RG6](N[NR],N[RG6](C3[RG6](N[NR],C3[RG6]))),C3[RG6]) &    ; DAP C3
ATD  317    *   6   3   *   *   [RG6,AR1.AR2.AR3] (C3[RG6](C3[RG6](N[NR])),C3[RG6](C3[RG6](N[RG6],N[NR]))) &   ; DAP C4
ATD  336    *   6   3   0   *   [RG6,AR1.AR2.AR3]   (N[NR],N2[RG6](C[RG6](O1,N[RG6])),C[RG6](C[RG6]))  &    ; Cytosine C4 parameters: JACS,113,2810(1991)
ATD  351    *   6   3   0   *   [RG6,AR1.AR2.AR3]       (N[NR],N[RG6],C[RG5,RG6](N[RG5],C[RG5,RG6]))   &    ; Adenine C6
ATD  362    *   6   3   *   *   [RG6,AR1.AR2.AR3] (N[NR],N[RG6](C[RG6](O)),N[RG6](C[RG5,RG6](N[RG5]))) &    ; Guanine C2
ATD  380    *   6   3   0   *   [RG6,AR1.AR2.AR3]   (N[NR],N3[RG6](C[RG6](O1,N[RG6])),C[RG6](C[RG6]))  &    ; CytH+ C4
ATD  457    *   6   3   *   *   [AR1.AR2.AR3]           (XX(O(P(XX,O,O))))                             &    ; Cipso  benzyl methylphosphonate
ATD  460    *   6   3   *   *   [AR1.AR2.AR3]           (XX(P(O(XX),O,O)))                             &    ; Cipso  methyl benzylphosphonate
ATD  463    *   6   3   *   *   [AR1.AR2.AR3]           (O(P(O,O,O)))                                  &    ; Cipso C6H5OPO3(2-)  use with #445-#447
ATD  472    *   6   3   *   *   [RG6,AR1.AR2.AR3]       (XA2(C(XA1)))                                  &    ; Cipso phenyl ester
ATD  488    *   6   3   0   *   [RG6,AR1.AR2.AR3]       (S(O,O,N3))                                    &    ; benzene C attached to S of sulfonamide
ATD  521    *   6   3   *   *   [RG6,AR1.AR2.AR3]       (N[RG6](C3[RG6](C3[RG6])),C3[RG6](C3[RG6]))    &    ; C1  in pyridine CHELPG6-31G* charges for 520-619
ATD  522    *   6   3   *   *   [RG6,AR1.AR2.AR3]       (C3[RG6](N[RG6](C3[RG6])),C3[RG6](C3[RG6]))    &    ; C2  in pyridine CHELPG6-31G* charges for 520-619
ATD  523    *   6   3   *   *   [RG6,AR1.AR2.AR3]       (C3[RG6](C3[RG6](N[RG6](C3[RG6]))),C3[RG6])    &    ; C3  in pyridine CHELPG6-31G* charges for 520-619
ATD  528    *   6   3   *   *   [RG6,AR1.AR2.AR3]           (N[RG6],C3[RG6](N[RG6]))                   &    ; C   in pyrazine
ATD  532    *   6   3   *   *   [RG6,AR1.AR2.AR3]           (N[RG6](C[RG6](N[RG6])),C[RG6](C[RG6]))    &    ; C4  in pyrimidine
ATD  533    *   6   3   *   *   [RG6,AR1.AR2.AR3]           (C[RG6](N[RG6](C[RG6])),C[RG6](N[RG6]))    &    ; C5  in pyrimidine
ATD  538    *   6   3   *   *   [RG6,AR1.AR2.AR3]       (N[RG6](N[RG6]),C3[RG6](C3[RG6](C3[RG6])))     &    ; C3  in pyridazine
ATD  539    *   6   3   *   *   [RG6,AR1.AR2.AR3]       (C3[RG6](N[RG6](N[RG6])),C3[RG6](C3[RG6]))     &    ; C4  in pyridazine
ATD  551    *   6   3   *   *   [RG5,AR1.AR2.AR3]       (C3[RG5](N[RG5]),C3[RG5](N[RG5]))              &    ; C4  in pyrazole
ATD  582    *   6   3   *   *   [RG5,AR1.AR2.AR3]       (C3[RG5](O[RG5]),C3[RG5](N[RG5]))              &    ; C4  in isoxazole
ATD  644    *   6   3   *   *   [RG6,AR1] (C[RG6](O2,C[RG6](C[RG5,RG6](N[RG5]))),C[RG6](C[RG5,RG6](C3[RG5](C3[RG5])))) &    ; C5  in serotonin
ATD  590    *   6   3   *   *   [RG6,AR1] (C[RG6](C[RG6](C[RG6](C[RG5,RG6](N[RG5])))),C[RG5,RG6](C3[RG5](C3[RG5]))) &    ; C4  in indole
ATD  591    *   6   3   *   *   [RG6,AR1] (C[RG6](C[RG6](C[RG5,RG6](N[RG5]))),C[RG6](C[RG5,RG6](C3[RG5](C3[RG5])))) &    ; C5  in indole
ATD  592    *   6   3   *   *   [RG6,AR1] (C[RG6](C[RG5,RG6](N[RG5])),C[RG6](C[RG6](C[RG5,RG6](C3[RG5](C3[RG5]))))) &    ; C6  in indole
ATD  593    *   6   3   *   *   [RG6,AR1] (C[RG5,RG6](N[RG5]),C[RG6](C[RG6](C[RG6](C[RG5,RG6](C3[RG5](C3[RG5])))))) &    ; C7  in indole
ATD  604    *   6   3   *   *   [RG6,AR1.AR2.AR3]     (N(C3[2RG6,AR1]),C3[RG6](C3[RG6](C3[2RG6,AR1]))) &    ; C2  in quinoline
ATD  605    *   6   3   *   *   [RG6,AR1.AR2.AR3]     (C3[RG6](N(C3[2RG6,AR1])),C3[RG6](C3[2RG6,AR1])) &    ; C3  in quinoline
ATD  606    *   6   3   *   *   [RG6,AR1.AR2.AR3]     (C3[2RG6,AR1],C3[RG6](C3[RG6](N(C3[2RG6,AR1])))) &    ; C4  in quinoline
ATD  607    *   6   3   *   *   [RG6,AR1.AR2.AR3] (C3[2RG6,AR1](C3[2RG6,AR1](C3[RG6],N[RG6]),C3[RG6]),C3[RG6]) &    ; C5  in quinoline
ATD  608    *   6   3   *   *   [RG6,AR1]         (C3[RG6](C3[2RG6,AR1](C3[2RG6,AR1](C3[RG6],N[RG6]),C3[RG6]),C3[RG6]),C3[RG6])  &    ; C6  in quinoline
ATD  609    *   6   3   *   *   [RG6,AR1]         (C3[RG6](C3[2RG6,AR1](N[RG6],C3[2RG6,AR1](C3[RG6],C3[RG6]))),C3[RG6](C3[RG6])) &    ; C7  in quinoline
ATD  610    *   6   3   *   *   [RG6,AR1]         (C3[2RG6,AR1](N[RG6](C3[RG6]),C3[2RG6,AR1](C3[RG6],C3[RG6])),C3[RG6](C3[RG6])) &    ; C8  in quinoline
ATD  611    *   6   3   *   *   [2RG6,AR1.AR2.AR3] (N[RG6](C3[RG6](C3[RG6](C3[RG6](C3[2RG6,AR1])))),C3[RG6](C3[RG6](C3[RG6](C3[RG6])))) &    ; C9  in quinoline
ATD  612    *   6   3   *   *   [2RG6,AR1.AR2.AR3] (C3[RG6](C3[RG6](C3[RG6](C3[RG6]))),C3[RG6](C3[RG6](C3[RG6](N[RG6](C3[2RG6,AR1]))))) &    ; C10 in quinoline
ATD  625    *   6   3   *   *   [RG6,AR1]               (N[AR1],C[AR1,AR2](N[AR2]))                    &    ; C6  in purine
ATD  647    *   6   3   *   *   [RG6,AR1.AR2.AR3] (N[RG6](C[2RG6](C[2RG6],C[2RG6](N[RG6],C[2RG6](C[RG6])))),C[RG6](C[RG6])) &    ; C2,C9  in 1,10-phenanthroline
ATD  648    *   6   3   *   *   [RG6,AR1.AR2.AR3] (C[RG6](N[RG6](C[2RG6](C[2RG6],C[2RG6](N[RG6],C[2RG6](C[RG6]))))),C[RG6]) &    ; C3,C8  in 1,10-phenanthroline
ATD  649    *   6   3   *   *   [RG6,AR1.AR2.AR3] (C[2RG6](C[RG6](C[RG6]),C[2RG6](N[RG6],C[2RG6](N[RG6],C[2RG6]))),C[RG6](C[RG6])) &    ; C4,C7  in 1,10-phenanthroline
ATD  650    *   6   3   *   *   [2RG6,AR1.AR2.AR3] (C[2RG6](N[RG6](C[RG6]),C[2RG6](N[RG6](C[RG6]))),C[RG6],C[RG6](C[RG6](C[2RG6](C[RG6])))) &    ; C12,C14 in 1,10-phenanthroline
ATD  651    *   6   3   *   *   [2RG6,AR1.AR2.AR3] (N[RG6](C[RG6]),C[2RG6](N[RG6](C[RG6]),C[2RG6](C[RG6],C[RG6])),C[2RG6](C[RG6],C[RG6])) &    ; C11,C13 in 1,10-phenanthroline
ATD  652    *   6   3   *   *   [RG6,AR1.AR2.AR3] (C[2RG6](C[2RG6](N[RG6])),C[RG6](C[2RG6](C[2RG6](N[RG6])))) &    ; C5  in 1,10-phenanthroline
//ATD  714    *   6   3   *   *   [AR1.AR2.AR3]             &    ; C in C5H5- cyclopentadienyl anion
//ATD  716    *   6   3   *   *   [AR1.AR2.AR3]             &    ; C in C5H5  cyclopentadienyl radical
ATD  718    *   6   3   0   *   [AR1.AR2.AR3]           (F,C3(H,C3(H)),C3(H,C3(H,C3(H))))              &    ; C(F) fluorobenzene
ATD  720    *   6   3   0   *   [AR1.AR2.AR3]           (F,C3(F,C3(F)),C3(F,C3(F,C3(F))))              &    ; C(F)  hexafluorobenzene
ATD  724    *   6   3   0   *   [AR1.AR2.AR3]           (C(F,F,F))                                     &    ; C(CF3) trifluoromethylbenzene
ATD  727    *   6   3   0   *   [AR1.AR2.AR3]           (F)                                            &    ; C(F)  difluorobenzenes
ATD  729    *   6   3   0   *   [AR1.AR2.AR3]           (Br)                                           &    ; C(Br) bromobenzene
ATD  731    *   6   3   0   *   [AR1.AR2.AR3]           (I)                                            &    ; C(I)  iodobenzene - tentative
ATD  735    *   6   3   0   *   [AR1.AR2.AR3]           (S(H))                                         &    ; C(S)  thiophenol
ATD  736    *   6   3   *   *   [RG6,AR1.AR2.AR3]       (C[RG6](C[RG6](C[RG6](C[NR](N3[NR],N[NR])))))  &    ; CG of Benzamidine
ATD  737    *   6   3   *   *   [RG6,AR1.AR2.AR3]       (C[RG6](C[RG6](C[NR](N3[NR],N[NR]))))          &    ; CD of Benzamidine
ATD  738    *   6   3   *   *   [RG6,AR1.AR2.AR3]       (C[RG6](C[NR](N3[NR],N[NR])))                  &    ; CE of Benzamidine
ATD  739    *   6   3   *   *   [RG6,AR1.AR2.AR3]       (C[NR](N3[NR],N[NR]))                          &    ; CZ of Benzamidine
ATD  768    *   6   3   0   *   [RG6,AR1.AR2.AR3]       (N3(O1,O1))                                    &    ; C(NO2) nitrobenzene
ATD  918    *   6   3   0   *   [RG6,AR1]               (C[AR1](C[AR1]),N3[NR](C4,C4),C[AR1](C[AR1]))  &    ; C(NH2) N,N-dimethylaniline
ATD  917    *   6   3   0   *   [RG6,AR1]               (C[AR1](C[AR1]),N3[NR](C4),C[AR1](C[AR1]))     &    ; C(NH2) N-methylaniline
ATD  916    *   6   3   0   *   [RG6,AR1]               (C[AR1](C[AR1]),N3[NR],C[AR1](C[AR1]))         &    ; C(NH2) aniline
ATD  145    *   6   3   *   *   [RG6,AR1.AR2.AR3]           &    ; Benzene C - 12 site JACS,112,4768-90. Use #145B for biphenyl
// CA    *   6   3   *   *   *                        (N3,N3,N3)              &
ATD  752    *   6   3   0   *   [NR]                    (N3[NR],N3[NR],N2[NR])                         &    ; CZ of neutral ARG
ATD  302    *   6   3   0   *   [NR]                    (N3[NR],N3[NR],N3[NR])                         &    ; C: guanidinium C+ (Arg CZ)
ATD  742    *   6   3   *   *   [NR]                    (C[RG6,AR1.AR2.AR3],N3[NR],N[NR])              &    ; C+ of Benzamidine
ATD  147    *   6   3   0   *   [2RG6,AR1.AR2.AR3]   &    ; Naphthalene fusion C (C9)

// CS types
ATD  544    *   6   3   *   *   [RG5,AR1.AR2.AR3]       (C3[RG5](N[RG5](C3[RG5])),C3[RG5])             &    ; C3  in pyrrole
ATD  568    *   6   3   *   *   [RG5,AR1.AR2.AR3]       (C3[RG5](XA2[RG5](C3[RG5])),C3[RG5])           &    ; C3  in furan
ATD  589    *   6   3   *   *   [RG5,AR1.AR2.AR3]       (C3[RG5](N[RG5](C[RG5,RG6])),C[RG5,RG6])       &    ; C3  in indole

// CU types
ATD  550    *   6   3   *   *   [RG5,AR1.AR2.AR3]       (N[RG5](N3[RG5](C3[RG5])),C3[RG5])             &    ; C3  in pyrazole
ATD  581    *   6   3   *   *   [RG5,AR1.AR2.AR3]       (N[RG5](O[RG5](C3[RG5])),C3[RG5])              &    ; C3  in isoxazole

// CX types
ATD  510    *   6   3   *   *   [RG5,AR1.AR2.AR3]       (C3(N3(H)),N3(H))                              &    ; CG, CD2 in HIP

// C! types
ATD  145B   *   6   3   0   *   [AR1.AR2.AR3]     (C[SB',AR1.AR2.AR3](C[AR1.AR2.AR3],C[AR1.AR2.AR3]))  &    ; Biphenyl C1

// C= types
ATD  150    *   6   3   1   *   [NR]                   (C3[SB',NR](C[DB']),C[DB'])                     &    ; diene =CH-CH= ; use #178 for =CR-CR=
ATD  178    *   6   3   0   *   [NR]                   (C3[SB',NR](C[DB']),C[DB'])                     &    ; diene =CR-CR= ; use #150 for =CH-CH=

// C    6    3    mop-up
ATD  141    *   6   3   &

// CZ types
ATD  261    *   6   2   0   *   [TB]                    (C[AR1],N1)                                    &    ; C(N)   benzonitrile
ATD  423    *   6   2   0   *   *                       (N[MI])                                        &    ; C2 in  CH2CN-   JACS 111,4190 (89)
ATD  754    *   6   2   0   *   [TB]                    (N1,C4)                                        &    ; C IN RCN  nitriles
ATD  925    *   6   2   1   *   [TB]    &    ; alkyne RC%CH terminal C   acetylene
ATD  927    *   6   2   0   *   [TB]                    (C4(H,H),C2(H))                                &    ; alkyne RC%CH C2 R-with 2 or 3 H
ATD  928    *   6   2   0   *   [TB]                    (C4(H),C2(H))                                  &    ; alkyne RC%CH C2 R-with 1 H
ATD  929    *   6   2   0   *   [TB]                    (C4,C2(H))                                     &    ; alkyne RC%CH C2 R-with no H or R=Phenyl
ATD  929    *   6   2   0   *   [TB]                    (C[AR1.AR2.AR3],C2(H))                         &    ; alkyne RC%CH C2 R-with no H or R=Phenyl
ATD  931    *   6   2   0   *   [TB]                    (C4,C2(C))                                     &    ; alkyne RC%CR

// C    6    2    mop-up
ATD  261    *   6   2   &

// Oxygen types
// O_3 types
ATD  269    *   8   1   *   *   *                       (C3(O2(H)))                                    &    ; Oc in CCOOH, R in RCOOH is neutral ; use #135-#140

// O_2 types
ATD  278    *   8   1   *   *   [DB]                    (C(H))                                         &    ; O: aldehyde
ATD  466    *   8   1   *   *   [DB]                    (C(O2(C)))                                     &    ; =O:  esters
ATD  281    *   8   1   *   *   [DB]                    (C3(C,C))                                      &    ; O: ketone

// O2 types
ATD  272    *   8   1   *   *   *                       (C(O))                                         &    ; O: O in COO- carboxylate,peptide terminus
ATD  441    *   8   1   *   *   *                       (P(O(XX),O(XX),O))                             &    ; O= in Me2PO4-, Me2PO4H
ATD  446    *   8   1   *   *   *                       (P(O(XX),O,O))                                 &    ; O= in MeOPO3--, MeOPO3H2
ATD  451    *   8   1   *   *   *                       (P(XX,O(XX),O))                                &    ; O= in MePO3Me-, MePO3HMe
// O2    *   8   1   *   *   *                         (P)              &

// O types
ATD  326    *   8   1   *   *   [NR] (C[RG6,AR1.AR2.AR3](N[RG6](C[RG6](C[RG6])),N[RG6](C[RG6](O[NR]))))  &    ; Uracil O-C2
ATD  328    *   8   1   *   *   [NR] (C[RG6,AR1.AR2.AR3](N[RG6](C[RG6](O[NR],N[RG6])),(C[RG6](C[RG6])))) &    ; Uracil O-C4
ATD  340    *   8   1   *   *   [NR]                   (C[RG6](N2[RG6](C(C[RG6])),N[RG6](C[RG6])))     &    ; Cytosine O-C2
ATD  370    *   8   1   *   *   [NR] (C[RG6](N[RG6](C3(N[NR],N2(C[RG5,RG6](N3[RG5])))),C[RG5,RG6](N2[RG5]))) &    ; Guanine O-C6
ATD  384    *   8   1   *   *   [NR]                 (C[RG6](N3[RG6](C(N[NR],C[RG6])),N[RG6](C[RG6]))) &    ; CytH+ O-C2
ATD  771    *   8   1   *   *   [NR]                   (C3(XA[RG5](C4[RG5](C4[NR],C4[RG5])),XA[RG5]))  &    ; propylene carbonate O (Luciennes param.)
ATD  788    *   8   1   *   *   [NR]                   (N(O,O))                                        &    ; O in NO3-
ATD  248    *   8   1   *   *   [DB,NR]                (C(N3,N3))                                      &    ; O in O=C(NH2)2  Urea Isr. J. Chem. 33, 323 (93)
ATD  236    *   8   1   *   *   [DB,NR]                (C3(N3))                                        &    ; O: C=O in amide.   Acyl R on C in amide is neutral -
ATD  253    *   8   1   *   *   *                      (C3(N3(C3(O1))))                                &    ; O   in imide
ATD  954    *   8   1   *   *   [NR]                   (C3(O,C4(H,H,N4(H,H,H))))                       &    ; glycine zwit. 6-31G* CHELPG charges
// O     *   8   1   *   *   *                         (C)                     &
// O     *   8   1   *   *   *                         (S)                     &

// ON types
ATD  761    *   8   1   *   *   *                      (N(C,O1))                                       &    ; O in nitro R-NO2

// OW types
ATD  795    *   8   2   2   &    ; O TIP4F Water

// OS types
ATD  179    *   8   2   *   *   *                      (C4,C3[RG6,AR1.AR2.AR3])                        &    ; O: anisole
ATD  186    *   8   2   *   *   *                      (C,C4(XE(C)))                                   &    ; O: acetal ether
ATD  186    *   8   2   *   *   *                      (C4,C4(XA(H)))                                  &    ; O: acetal ether
ATD  442    *   8   2   *   *   *                      (XX4,P(O(XX4),O,O))                             &    ; OMe in Me2PO4-, Me2PO4H   dimethylphosphate
ATD  447    *   8   2   *   *   *                      (XX4,P(O,O,O))                                  &    ; OMe in MeOPO3--, MeOPO3H2  methyl phosphate
ATD  452    *   8   2   *   *   *                      (XX4,P(XX4,O,O))                                &    ; OMe in MePO3Me-, MePO3HMe  methyl methyl phosphate
ATD  467    *   8   2   *   *   [NR]                   (C[NR],C3[NR](XA1))                             &    ; -OR: alkyl ester
ATD  473    *   8   2   *   *   [NR]                   (C[AR1.AR2.AR3],C3[NR](XA1))                    &    ; -OR: phenyl ester
ATD  566    *   8   2   *   *   [RG5,AR1.AR2.AR3]      (C3[RG5](C3[RG5]),C3[RG5](C3[RG5]))             &    ; O in furan
ATD  571    *   8   2   *   *   [RG5,AR1.AR2.AR3]      (C3[RG5](N3[RG5]),C3[RG5](C3[RG5]))             &    ; O in oxazole
ATD  579    *   8   2   *   *   [RG5,AR1.AR2.AR3]      (N[RG5](C3[RG5]),C3[RG5](C3[RG5]))              &    ; O in isoxazole
ATD  773    *   8   2   *   *   [RG5]                  (C3(O1,O[RG5](C4[RG5])),C4[RG5])                &    ; propylene carbonate OS
ATD  180    *   8   2   *   *   *                      (C4,C4)                                         &    ; O: dialkyl ether
// ATD  395    *   8   2   *   *   *                      (P(O,O,O))                                      &    ; O(-) dimethylphosphate anion
ATD  441    *   8   2   *   *   *                      (P(O(XX),O(XX),O))                              &    ; O(-) dimethylphosphate anion
ATD  446    *   8   2   *   *   *                      (P(O(XX),O,O))                                  &    ; O(-) dimethylphosphate anion

// OH types
ATD  162    *   8   2   *   *   *                      (C4(C(F,F,F)))                                  &    ; OH  Trifluoroethanol
ATD  167    *   8   2   *   *   *                      (C[AR1.AR2.AR3])                                &    ; O  phenol  atom C, H 145 & 146
ATD  171    *   8   2   *   *   *                      (C4(C4(O2),C4(O2)))                             &    ; O: triols
ATD  171    *   8   2   *   *   *                      (C4(C4(O2,C4(O2))))                             &    ; O: triols
ATD  169    *   8   2   *   *   *                      (C4(C4(O2)))                                    &    ; O: diols
ATD  187    *   8   2   1   *   *                      (C4(XE(C)))                                     &    ; O(H): hemiacetal
ATD  268    *   8   2   1   *   *                      (C3(O),H)                                       &    ; Oh in CCOOH R in RCOOH is neutral; use #135-#140
ATD  420    *   8   2   0   *   [MI]                   (C4)                                            &    ; O  in  CH3O-
ATD  434    *   8   2   1   *   [MI]                   &    ; O in OH-  Hyroxide O-H = 0.953 A
ATD  154    *   8   2   1   *   *                      (C4)                                            &    ; all-atom O: mono alcohols

// OU types
ATD  437    *   8   1   *   *   *                      (U)                                             &    ; O in UO2+ r(U-O) = 1.80 A

// OY types
ATD  475    *   8   *   *   *   *                      (S(N3,O1))                                      &    ; O in sulfonamide, S(=O)2(OR)
ATD  494    *   8   1   *   *   *                      (S4(O1,C))                                      &    ; O in sulfone
ATD  497    *   8   1   *   *   *                      (S3(C,C))                                       &    ; sulfoxide - all atom

// O mop-up
ATD  272    *   8   1   &        ; Default for O types.
ATD  154    *   8   2   1   &    ; Anything else that makes OH
ATD  180    *   8   2   &        ; Default for all other oxygens

// Sulfur types
// SH types
ATD  734    *  16  2   1   *   *                       (C[AR1.AR2.AR3])                                &    ; all-atom S: thiophenol (HS is #204)
ATD  417    *  16  2   1   *   *                       (C(H,H,H))                                      &    ; S  in  CH3S-
ATD  200    *  16  2   1   *   *                       (C)                                             &    ; all-atom S: thiols
ATD  201    *  16  2   2   &    ; S   IN H2S  JPC,90,6379 (1986)

// S types
ATD  222    *  16  2   0   *   *                       (C3[RG6,AR1.AR2.AR3],C4)                        &    ; S in thioanisoles
ATD  202    *  16  2   0   *   [DB]                    (C[DB])                                         &    ; all-atom S: sulfides, S=C
ATD  202    *  16  2   0   *   *                       (C,C)                                           &    ; all-atom S: sulfides, S=C
ATD  203    *  16  2   0   *   *                       (C,S)                                           &    ; all-atom S: disulfides
ATD  633    *  16  2   0   *   [RG5,AR1.AR2.AR3]       (C3[RG5](N3[RG5]),C3[RG5](C3[RG5]))             &    ; S   in thiazole
// SO    *   16  4   &

// SY types
ATD  474    *  16  4   *   *   *                       (C,O1,O1,N3)                                    &    ; S in sulfonamide, S(=O)2(OR)

// SY2 types
ATD  493    *  16  4   *   *   *                       (C4,O,O,C4)                                     &    ; S in sulfone

// SZ types
ATD  496    *  16  3   *   *   *                       (C4,C4,O1)                                      &    ; sulfoxide - all atom

// S mop-up
ATD  200    *  16  2   1   &    ; Anything else that makes SH
ATD  202    *  16  2   &        ; Anything else that makes -S-
ATD  474    *  16  &            ; Default all other S

// Nitrogen types
// NB types
ATD  511    *   7   2   0   *   [RG5,AR2]              (C3(H),C3(H))                                   &    ; NE in HID, ND in HIE
ATD  511    *   7   2   0   *   [RG5,AR2]              (C3(H),C3(C4))                                  &    ; NE in HID, ND in HIE
ATD  352    *   7   2   0   *   [RG5,AR1.AR2.AR3] (C[RG5](N3(C[RG5,RG6](N2[RG6]))),C[RG5,RG6](C[RG6](XE,N[RG6]))) &    ; Adenine & Guanine N7
ATD  549    *   7   2   *   *   [RG5,AR1.AR2.AR3]      (N3[RG5](C3[RG5]),C3[RG5](C3[RG5]))             &    ; N2 in pyrazole
ATD  559    *   7   2   *   *   [RG5,AR1.AR2.AR3]      (C3[RG5](N3[RG5]),C3[RG5](C3[RG5]))             &    ; N3 in imidazole
ATD  573    *   7   2   *   *   [RG5,AR1.AR2.AR3]      (C3[RG5](O[RG5]),C3[RG5](C3[RG5]))              &    ; N in oxazole
ATD  580    *   7   2   *   *   [RG5,AR1.AR2.AR3]      (O[RG5](C3[RG5]),C3[RG5](C3[RG5]))              &    ; N in isoxazole
ATD  626    *   7   2   0   *   [RG5,AR1.AR2.AR3] (C[RG5](N3(C[RG5,RG6](N2[RG6]))),C[RG5,RG6](C[RG6](N[RG6]))) &    ; N7 in purine
ATD  635    *   7   2   *   *   [RG5,AR1.AR2.AR3]      (C3[RG5](S2[RG5]),C3[RG5](C3[RG5]))             &    ; N in thiazole
ATD  542    *   7   2   *   *   [RG5,AR1.AR2.AR3]      (C3[RG5](C3[RG5]),C3[RG5](C3[RG5]))             &    ; N in pyrrole

// NC types
ATD  311    *   7   2   *   *   [RG6,AR1.AR2.AR3] (C3[RG6](C3[RG6](C3[RG6]),N[NR]),C3[RG6](C3[RG6],N[NR])) &    ; DAP N1   (Diaminopyridine)
ATD  335    *   7   2   0   *   [RG6,AR1.AR2.AR3]   (C[RG6](O1,N[RG6](C[RG6])),C[RG6](N[NR],C[RG6]))   &    ; Cytosine N3
ATD  346    *   7   2   *   *   [RG6,AR1] (C3(N2(C[AR2,AR1](N3[AR2]))),C3(N[NR],C[AR2,AR1](N2[AR2])))  &    ; Adenine N1
ATD  348    *   7   2   *   *   [RG6,AR1] (C[AR2,AR1](N3[AR2]),C3(N[AR1](C[AR1](N[NR],C[AR2,AR1](N2[AR2]))))) &    ; Adenine N3
ATD  363    *   7   2   *   *   [RG6,AR1.AR2.AR3] (C[RG5,RG6](N3[RG5]),C3(N[NR],N[RG6](C[RG6](O1,C[RG5,RG6](N2[RG5]))))) &    ; Guanine N3
ATD  520    *   7   2   *   *   [RG6,AR1.AR2.AR3]         (C3[RG6](C3[RG6](C3[RG6])),C3[RG6](C3[RG6])) &    ; N in pyridine 6-31G*
ATD  527    *   7   2   *   *   [RG6,AR1.AR2.AR3]         (C3[RG6](C3[RG6](N[RG6])),C3[RG6](C3[RG6]))  &    ; N in pyrazine
ATD  530    *   7   2   *   *   [RG6,AR1.AR2.AR3]         (C[RG6](N[RG6](C[RG6])),C[RG6](C[RG6]))      &    ; N in pyrimidine
ATD  537    *   7   2   *   *   [RG6,AR1.AR2.AR3]         (C3[RG6](C3[RG6](C3[RG6])),N[RG6](C3[RG6]))  &    ; N in pyridazine
ATD  603    *   7   2   *   *   [RG6,AR1.AR2.AR3] (C3[RG6](C3[RG6](C3[RG6](C[2RG6,AR1]))),C[2RG6,AR1](C[AR1](C[AR1](C[AR1](C[AR1]))))) &    ; N1 in quinoline
ATD  620    *   7   2   *   *   [RG6,AR1] (C[RG6](C[RG5,RG6](N[RG5])),C[RG6](N[RG6](C[RG5,RG6](N[RG5]))))     &    ; N1 in purine
ATD  622    *   7   2   *   *   [RG6,AR1] (C[RG5,RG6](N[RG5]),C[RG6](N[RG6](C[RG6](C[RG5,RG6](N[RG5])))))     &    ; N3 in purine
ATD  641    *   7   2   *   *   [RG6,AR1.AR2.AR3]         (C3[RG6](N2[RG6]),C3[RG6](N2[RG6](C3[RG6]))) &    ; N in 1,3,5-triazine
ATD  646    *   7   2   *   *   [RG6,AR1.AR2.AR3] (C[2RG6](C[2RG6](N[RG6],C[2RG6]),C[2RG6]),C[RG6](C[RG6](C[RG6]))) &    ; N1,N10 in 1,10-phenanthroline

// N2 types
ATD  300    *   7   3   2   *   [NR]                   (C3(N,N3(C)))                                   &    ; N: guanidinium NH2
ATD  303    *   7   3   1   *   [NR]                   (C3(N3,N3),C)                                   &    ; N: guanidinium NHR
ATD  313    *   7   *   *   *   [NR] (C[RG6,AR1.AR2.AR3](C3[RG6](C3[RG6]),N[RG6](C3[RG6](N[NR],C3[RG6])))) &    ; DAP N-amine
ATD  341    *   7   3   *   *   [NR]       (C[RG6](N2[RG6](C[RG6](O1,N[RG6])),C[RG6](C[RG6])))         &    ; Cytosine N-C4
ATD  356    *   7   3   *   *   [NR] (C[AR1](N[AR1](C3(N2(C[RG5,AR1](N3[RG5])))),C[RG5,AR1](N2[RG5]))) &    ; Adenine & Guanine N-C6
ATD  368    *   7   3   *   *   [NR] (C[RG6](N2(C[RG5,RG6](N3[RG5])),N[RG6](C[RG6](O1,C[RG5,RG6](N2[RG5]))))) &    ; Guanine N-C2
ATD  386    *   7   *   *   *   [NR]       (C[RG6](N3[RG6](C[RG6](O1,N[RG6])),C[RG6](C[RG6])))         &    ; CytH+ N-C4
ATD  743    *   7   3   2   *   [NR]                   (C(C[AR1.AR2.AR3],N))                           &    ; N-H2 of Benzamidine
// N2    *   7   3   *   *   [NR]                      (XX[AR1.AR2.AR3])        &    

// NO types
ATD  767    *   7   3   0   *   [NR]                   (C[AR1.AR2.AR3],O1,O1)                          &    ; N in nitro Ar-NO2
ATD  760    *   7   3   0   *   *                      (C,O1,O1)                                       &    ; N in nitro R-NO2

// N* types
ATD  319B   *   7   3   0   *   [RG6,AR1.AR2.AR3] (C(O[NR],N[RG6](C[RG6](O[NR]))),C[RG6](C[RG6]),C4(O2,C4(O2)))    &    ; Uracil & Thymine N1 - only for nucleoside
ATD  333B   *   7   3   0   *   [RG6,AR1.AR2.AR3] (C[RG6](O1,N2[RG6](C[RG6](N[NR]))),C[RG6](C[RG6]),C4(O2,C4(O2))) &    ; Cytosine N1 - for nucleoside
ATD  333B   *   7   3   0   *   [RG6,AR1.AR2.AR3] (C[RG6](O1,N2[RG6](C[RG6](H))),C[RG6](C[RG6]),C4(O2,C4(O2)))     &    ; Zebularine N1 - for nucleoside
ATD  354B   *   7   3   0   *   [RG5,AR1.AR2.AR3] (C[RG5,RG6](N2[RG6]),C4(O2,C4(O2)),C[RG5](N2[RG5]))  &    ; Adenine & Guanine N9 - nucleoside only
ATD  377B   *   7   3   *   *   [RG6,AR1.AR2.AR3] (C[RG6](O1,N3[RG6](C[RG6](N[NR]))),C[RG6](C[RG6]),C4(O2,C4(O2))) &    ; CytH+ N1 - nucleoside only

// NA types
ATD  319    *   7   3   *   *   [RG6,AR1.AR2.AR3] (C[RG6](O[NR],N[RG6](C[RG6](O[NR]))),C[RG6](C[RG6])) &    ; Uracil & Thymine N1 - use #319B for nucleoside
ATD  321    *   7   3   1   *   [RG6,AR1.AR2.AR3] (C[RG6](O[NR],N[RG6](C[RG6](C[RG6]))),C[RG6](O[NR])) &    ; Uracil & Thymine N3
ATD  333    *   7   3   *   *   [RG6,AR1.AR2.AR3]   (C[RG6](O1,N2[RG6](C[RG6](N[NR]))),C[RG6](C[RG6])) &    ; Cytosine N1 -use #333B for nucleoside
ATD  354    *   7   3   *   *   [RG5,AR1.AR2.AR3] (C[RG5,RG6](N2[RG6]),C[RG5](N2[RG5](C[RG5,RG6](C[RG6](XE[NR]))))) &    ; Adenine & Guanine N9 - use #354B for nucleoside
ATD  361    *   7   3   *   *   [RG5,AR1.AR2.AR3]      (C(N[NR],N[RG6]),C(O[NR],C[RG5,RG6](N2)))       &    ; Guanine N1
ATD  377    *   7   3   *   *   [RG6,AR1.AR2.AR3]   (C[RG6](O1,N3[RG6](C[RG6](N[NR]))),C[RG6](C[RG6])) &    ; CytH+ N1 Use #377B for nucleoside.
ATD  379    *   7   3   *   *   [RG6,AR1.AR2.AR3]   (C[RG6](N[NR],C[RG6]),C[RG6](O1,N[RG6](C[RG6])))   &    ; CytH+ N3 Protonated cytosine.
ATD  503    *   7   3   1   *   [RG5,AR1.AR2.AR3]      (C[RG5,RG6],C3[RG5](C3[RG5](C4,C[RG5,RG6])))    &    ; NE in Trp
ATD  512    *   7   3   1   *   [RG5,AR1.AR2.AR3]      (C3(N3[RG5]),C3(C3,C4))                         &    ; N in HIP
ATD  512    *   7   3   1   *   [RG5,AR1.AR2.AR3]      (C3(N3[RG5]),C3(C3(C4)))                        &    ; N in HIP
ATD  542    *   7   3   *   *   [RG5,AR1.AR2.AR3]      (C3[RG5](C3[RG5]),C3[RG5](C3[RG5]))             &    ; N in pyrrole
ATD  548    *   7   3   *   *   [RG5,AR1.AR2.AR3]      (N[RG5](C3[RG5]),C3[RG5](C3[RG5]))              &    ; N1 in pyrazole
ATD  557    *   7   3   *   *   [RG5,AR1.AR2.AR3]      (C3[RG5](N[RG5]),C3[RG5](C3[RG5]))              &    ; N1 in imidazole
ATD  587    *   7   3   *   *   [RG5,AR1.AR2.AR3]      (C3[RG5](C3[RG5](C[RG5,RG6])),C[RG5,RG6])       &    ; N1 in indole
ATD  628    *   7   3   *   *   [RG5,AR1.AR2.AR3]      (C[RG5,RG6](N2[RG6]),C[RG5](N2[RG5]))           &    ; N9 in purine

// N types
ATD  251    *   7   3   *   *   *                      (C3(XA1),C3(XA1))                               &    ; N   in imide
ATD  249    *   7   3   2   *   [NR]                   (C3[NR](O1,N(H,H)))                             &    ; N in O=C(NH2)2  Urea Isr. J. Chem. 33, 323 (93)
ATD  265    *   7   3   1   *   [NR]                   (C[AR1.AR2.AR3],C3(XA1,C4))                     &    ; N: N-phenylacetamide
ATD  478    *   7   3   2   *   *                      (C,S(O1,O1))                                    &    ; N: primary amide of sulfonamide
ATD  480    *   7   3   1   *   *                      (C,C,S(O1,O1))                                  &    ; N secondary amide of sulfonamide
ATD  237    *   7   3   2   *   *                      (C3(O1))                                        &    ; N: primary amide.  use alkane parammeters.
ATD  238    *   7   3   1   *   *                      (C3(O1),C)                                      &    ; N: secondary amide, peptide bond (see #279 for formyl H)
ATD  239    *   7   3   0   *   *                      (C3(O1),C,C)                                    &    ; N: tertiary amide, Pro in peptide bond
ATD  787    *   7   3   *   *   *                      (O,O,O)                                         &    ; N in NO3-

// N3 types
ATD  953    *   7   4   3   *   *                      (C4(C(O1,O),H,H,H))                             &    ; glycine zwit. 6-31G* CHELPG charges
ATD  286    *   7   4   4   &    ; N (NH4+) JPC,90,2174 (1986)
ATD  287    *   7   4   3   &    ; N (RNH3+) JPC,90,2174 (1986)
ATD  288    *   7   4   0   &    ; N (R4N+)  JPC,90,2174 (1986)
ATD  309    *   7   4   2   &    ; N (R2NH2+), N-terminal PRO NH2+
ATD  427    *   7   4   1   *   *                      (C(H,H,H))                                      &    ; N  in  CH3NH-
ATD  940    *   7   4   1   &    ; N (R3NH+)

// NY types
ATD  749    *   7   3   1   *   [NR]                   (C[NR],C3[NR](N2[NR],N3[NR]))                   &    ; NE of neutral ARG
ATD  751    *   7   3   2   *   [NR]                   (C3[NR](N3[NR](C[NR]),N2[NR]))                  &    ; N2 of neutral ARG (H2N-CZ)

// NZ types
ATD  262    *   7   1   0   *   [TB]                   (C(C[RG6,AR1.AR2.AR3]))                         &    ; N      benzonitrile
ATD  424    *   7   1   0   *   [MI]             &    ; N  in  CH2CN-
ATD  750    *   7   2   1   *   [DB,NR]                (C3[NR](N3[NR](C[NR]),N3[NR]))                  &    ; N1 of neutral ARG (HN=CZ)
ATD  753    *   7   1   0   *   [TB]                   (C(C4))                                         &    ; N IN RCN  nitriles

// NT types
ATD  902    *   7   3   *   *   *                      (C4,C4,C4)                                      &    ; N tertiary  amines
ATD  901    *   7   3   *   *   *                      (C4,C4)                                         &    ; N secondary amines, aziridine N1
ATD  900    *   7   3   *   *   *                      (C4)                                            &    ; N primary   amines

// N types mop-up
ATD  300    *   7   3   2   *   *                      (C3(N,N3(C)))                                   &    ; N: in ring NH2
ATD  303    *   7   3   1   *   *                      (C3(N3,N3),C)                                   &    ; N: in ring NHR
ATD  237    *   7   3   2   &    ; Default -NH2
ATD  238    *   7   3   1   &    ; Default -N(H)-
ATD  239    *   7   3   0   &    ; Default -N(-)-
ATD  750    *   7   2   &        ; Default -N-
ATD  753    *   7   1   &        ; Default N-


// Phosphorous types
// P types
ATD  440    *  15   4   0   *   *                      (O(XX4),O(XX4),O,O)                             &    ; P in  Me2PO4-, Me2PO4H
ATD  445    *  15   4   0   *   *                      (O(XX4),O,O,O)                                  &    ; P  in MeOPO3--, MeOPO3H2
ATD  450    *  15   4   0   *   *                      (C4,O(XX4),O,O)                                 &    ; P  in MePO3Me-, MePO3HMe
ATD  785    *  15   6   0   *   *                      (F,F,F,F,F,F)                                   &    ; P in PF6-

// P+ types
ATD  781    *  15   4   *   *   [PL]             &    ; phosphonium R4P+


// Hydrogen types
// H3 types
ATD  941    *   1   1   *   *   *                      (N4(C,C,C))                                     &    ; H (R3NH+)
ATD  310    *   1   1   *   *   *                      (N4(C,C))                                       &    ; H (R2NH2+)
ATD  955    *   1   1   *   *   *                      (N4(C(H,H,C3(O1,O))))                           &    ; glycine zwit. 6-31G* CHELPG charges
ATD  290    *   1   1   *   *   *                      (N4(C))                                         &    ; H (RNH3+) JPC,90,2174 (1986)
ATD  289    *   1   1   *   *   *                      (N4)                                            &    ; H (NH4+)  JPC,90,2174 (1986)
ATD  304    *   1   1   *   *   *                      (N3[NR](C3[NR](N3[NR],N[NR]),C))                &    ; H: guanidinium NHR
ATD  301    *   1   1   *   *   *                      (N3[NR](C3[NR](N[NR],N3[NR](C[NR]))))           &    ; H: guanidinium NH2

// H types
ATD  240    *   1   1   *   *   *                      (N3(C3(O1,C),H))                                &    ; H on N: primary amide
ATD  241    *   1   1   *   *   *                      (N3(C3(O1),C))                                  &    ; H on N: secondary amide
ATD  250    *   1   1   *   *   *                      (N3[NR](C3[NR](O1,N3[NR])))                     &    ; H in O=C(NH2)2  Urea
ATD  254    *   1   1   *   *   *                      (N3(C3(O1,C),C3(O1,C)))                         &    ; H(N) in imide
ATD  314    *   1   1   *   *   * (N[NR](C[RG6,AR1.AR2.AR3](C3[RG6](C3[RG6]),N[RG6](C3[RG6](N[NR],C3[RG6]))))) &    ; DAP H-amine
ATD  325    *   1   1   *   *   * (N[RG6,AR1.AR2.AR3](C[RG6](O[NR],N[RG6](C[RG6](O[NR]))),C[RG6](C[RG6]))) &    ; Uracil & Thymine H-N1
ATD  327    *   1   1   *   *   * (N[RG6,AR1.AR2.AR3](C[RG6](O[NR],N[RG6](C[RG6](C[RG6]))),C[RG6](O[NR]))) &    ; Uracil H-N3
ATD  339    *   1   1   *   *   *  (N[RG6,AR1.AR2.AR3](C[RG6](O1,N[RG6](C[RG6](N[NR]))),C[RG6](C[RG6]))) &    ; Cytosine H-N1
ATD  342    *   1   1   *   *   *  (N[NR](C[RG6,AR1.AR2.AR3](N2[RG6](C[RG6](O1,N[RG6]))),C[RG6](C[RG6]))) &    ; Cytosine H-NC4/N3
ATD  343    *   1   1   *   *   *  (N[NR](C[RG6,AR1.AR2.AR3](N2[RG6](C[RG6](O1,N[RG6]))),C[RG6](C[RG6]))) &    ; Cytosine H-NC4/C5
ATD  357    *   1   1   *   *   *                      (N[NR](C[AR1](C[RG5,AR1](N[RG5]),N[AR1])))      &    ; Adenine & Guanine H-NC6/N1
ATD  358    *   1   1   *   *   *                      (N[NR](C[AR1](C[RG5,AR1](N[RG5]),N[AR1])))      &    ; Adenine & Guanine H-NC6/C5
ATD  360    *   1   1   *   *   *                      (N[RG5](C[RG5,RG6](N[RG6]),C[RG5](N[RG5])))     &    ; Adenine & Guanine H-N9 Guanine
ATD  367    *   1   1   *   *   *                      (N[RG6](C[RG6](N[NR]),C[RG6](C[RG5,RG6])))      &    ; Guanine H-N1
ATD  369    *   1   1   *   *   *                      (N[NR](C[RG6](N,N(C[RG5,RG6]))))                &    ; Guanine H-NC2
ATD  383    *   1   1   *   *   *  (N[RG6,AR1.AR2.AR3](C[RG6](O1,N3[RG6](C[RG6](N[NR]))),C[RG6](C[RG6]))) &    ; CytH+ H-N1
ATD  385    *   1   1   *   *   *  (N3[RG6,AR1.AR2.AR3](C[RG6](N[NR],C[RG6]),C[RG6](O1,N[RG6](C[RG6]))))  &    ; CytH+ H-N3
ATD  387    *   1   1   *   *   *  (N[NR](C[RG6,AR1.AR2.AR3](N3[RG6](C[RG6](O1,N[RG6]))),C[RG6](C[RG6]))) &    ; CytH+ H-NC4/N3
ATD  388    *   1   1   *   *   *  (N[NR](C[RG6,AR1.AR2.AR3](N3[RG6](C[RG6](O1,N[RG6]))),C[RG6](C[RG6]))) &    ; CytH+ H-NC4/C5
ATD  428    *   1   1   *   *   *                      (N[MI])                                         &    ; HN in  CH3NH-
ATD  481    *   1   1   *   *   *                      (N3(C,C,S(O1,O1)))                              &    ; H on N: secondary sulfonamide
ATD  479    *   1   1   *   *   *                      (N3(C,S(O1,O1)))                                &    ; H on N: primary sulfonamide
ATD  504    *   1   1   *   *   *     (N[RG5,AR1.AR2.AR3](C3[RG5](C3[RG5](C4,C[RG5,RG6])),C[RG5,RG6])) &    ; H on NE in Trp
ATD  513    *   1   1   *   *   *                      (N3[RG5,AR1.AR2.AR3](C3(N3[RG5]),C3(C3,C4)))    &    ; H on N in HIP
ATD  513    *   1   1   *   *   *                      (N3[RG5,AR1.AR2.AR3](C3(N3[RG5]),C3(C3(C4))))   &    ; H on N in HIP
ATD  545    *   1   1   *   *   *              (N[RG5,AR1.AR2.AR3](C3[RG5](C3[RG5]),C3[RG5](C3[RG5]))) &    ; H1  in pyrrole
ATD  553    *   1   1   *   *   *              (N3[RG5,AR1.AR2.AR3](N[RG5](C3[RG5]),C3[RG5](C3[RG5]))) &    ; H1  in pyrazole
ATD  562    *   1   1   *   *   *                      (N3[RG5](C3[RG5](N[RG5]),C3[RG5](C3[RG5])))     &    ; H1  in imidazole
ATD  596    *   1   1   *   *   *        (N[RG5,AR1.AR2.AR3](C3[RG5](C3[RG5](C[RG5,RG6])),C[RG5,RG6])) &    ; H1  in indole
ATD  632    *   1   1   *   *   *           (N3[RG5,AR1.AR2.AR3](C[RG5,RG6](N2[RG6]),C[RG5](N2[RG5]))) &    ; H9  in purine
ATD  745    *   1   1   *   2   [NR]                   (N3(C[NR](C[AR1.AR2.AR3],N)))                   &    ; H2-N of Benzamidine
ATD  744    *   1   1   *   2   [NR]                   (N(C[NR](C[AR1.AR2.AR3],N3)))                   &    ; H1-N of Benzamidine
ATD  910    *   1   1   *   *   *                      (N3(XX,XX))                                     &    ; H(N) secondary amines
ATD  909    *   1   1   *   *   *                      (N3)                                            &    ; H(N) primary   amines

// HO types
ATD  163    *   1   1   *   *   *                      (O2(C(C(F,F,F))))                               &    ; HO  Trifluoroethanol
ATD  168    *   1   1   *   *   *                      (O2(C[AR1.AR2.AR3]))                            &    ; H  phenol
ATD  172    *   1   1   *   *   *                      (O2(C4(C4(O2),C4(O2))))                         &    ; H(O): triols
ATD  172    *   1   1   *   *   *                      (O2(C4(C4(O2),(C4(O2)))))                       &    ; H(O): triols
ATD  170    *   1   1   *   *   *                      (O2(C4(C4(O2))))                                &    ; H(O): diols
ATD  188    *   1   1   *   *   *                      (O(C4(XE(C))))                                  &    ; H(O): hemiacetal
ATD  435    *   1   1   *   *   *                      (O[MI])                                         &    ; H in OH- JACS 108, 2517 (86)
ATD  155    *   1   1   *   *   *                      (O2(C4))                                        &    ; all-atom H(O): mono alcohols, OP(=O)2
ATD  155    *   1   1   *   *   *                      (O2(P(O1,O1)))                                  &    ; all-atom H(O): mono alcohols, OP(=O)2
ATD  270    *   1   1   *   *   *                      (O2(C3(O)))                                     &    ; H in CCOOH

// HS types
ATD  205    *   1   1   *   *   *                      (S(H))                                          &    ; H in H2S  JPC,90,6379 (1986)
ATD  204    *   1   1   *   *   *                      (S)                                             &    ; all-atom H(S): thiols

// HW types
ATD  796    *   1   1   *   *   *                      (O(H1))                                         &    ; H TIP4F Water

// H5 types
ATD  355    *   1   1   *   2   * (C[RG6](N2(C[RG5,RG6](N3[RG5])),N[RG6](C[RG6](N[NR],C[RG5,RG6](N2[RG5])))))   &    ; Adenine & Guanine H-C2
ATD  359    *   1   1   *   2   * (C[RG5](N3[RG5](C[RG5,RG6](N2[RG6])),N2[RG5](C[RG5,RG6](C[RG6](XE,N[RG6]))))) &    ; Adenine & Guanine H-C8 Guanine

// H4 types
ATD  345    *   1   1   *   1   *        (C[RG6,AR1.AR2.AR3](C[RG6](C[RG6](N[NR],N2[RG6])),N[RG6](C[RG6](O1)))) &    ; Cytosine H-C6
ATD  390    *   1   1   *   1   *        (C[RG6,AR1.AR2.AR3](C[RG6](C[RG6](N[NR],N3[RG6])),N[RG6](C[RG6](O1)))) &    ; CytH+ H-C6

// HC types
ATD  444    *   1   *   *   *   *                      (XX4(O(P(O(XX),O,O))))                          &    ; H in Me2PO4-, Me2PO4H    6-31+G* CHELPG
ATD  449    *   1   *   *   *   *                      (XX4(O(P(O,O,O))))                              &    ; H in MeOPO3--, MeOPO3H2
ATD  459    *   1   *   *   *   *                      (XX4(XX[AR1.AR2.AR3],O(P(XX4,O,O))))            &    ; H(CO) benzyl methylphosphonate
ATD  462    *   1   *   *   *   *                      (XX4(XX[AR1.AR2.AR3],P(O(XX4),O,O)))            &    ; H(CP) methyl benzylphosphonate
ATD  454    *   1   *   *   *   *                      (XX4(O(P(XX4,O,O))))                            &    ; H(CO) MePO3Me-, MePO3HMe     6-31+G* CHELPG
ATD  456    *   1   *   *   *   *                      (XX4(P(O(XX4),O,O)))                            &    ; H(CP) MePO3Me-, MePO3HMe
ATD  176    *   1   *   *   1   *                      (C4(C4(O2),C4(O2),O2))                          &    ; H(CXOH): triols
ATD  176    *   1   *   *   1   *                      (C4(C4(O2,C4(O2)),O2))                          &    ; H(CXOH): triols
ATD  153    *   1   *   *   *   *                      (C4(H,C,Cl))                                    &    ; H in RCH2Cl in alkyl chlorides
ATD  156    *   1   *   *   1   *                      (C4(H,H,O2))                                    &    ; all-atom H(C): methanol
ATD  165    *   1   *   *   *   *                      (C4(H,O2,C4(F,F,F)))                            &    ; H Trifluoroethanol
ATD  190    *   1   *   *   *   *                      (C4(H,XA(C),XE(C)))                             &    ; H(CHO2): acetal OCH2O
ATD  192    *   1   *   *   *   *                      (C4(H,XE(C),XA(H)))                             &    ; H(CHO2): hemiacetal OCH2OH
ATD  194    *   1   *   *   *   *                      (C4(C,XA(C),XE(C)))                             &    ; H(CHO2): acetal OCHRO
ATD  196    *   1   *   *   *   *                      (C4(C,XE(C),XA(H)))                             &    ; H(C2O2): hemiacetal OCHROH
ATD  255    *   1   *   *   *   *                      (C3(XA1,N3(C3(XA1,C))))                         &    ; H(C) in formimide
ATD  255    *   1   *   *   *   *                      (C3(XA1,N3(C3(XA1,H))))                         &    ; H(C) in formimide
ATD  279    *   1   *   *   1   *                      (C3(O1,C4))                                     &    ; H-alpha in aldehyde & formamide
ATD  279    *   1   *   *   2   *                      (C3(O1,N3))                                     &    ; H-alpha in aldehyde & formamide
ATD  282    *   1   *   *   *   *                      (C4(C3(O1,H)))                                  &    ; H on C-alpha in ketone & aldehyde
ATD  282    *   1   *   *   *   *                      (C4(C3(O1,C4)))                                 &    ; H on C-alpha in ketone & aldehyde
ATD  185    *   1   *   *   *   *                      (C(O(C(XH))))                                   &    ; H(COR): alpha H ether
ATD  329    *   1   *   *   *   * (C[RG6,AR1.AR2.AR3](C[RG6](O[NR],N[RG6]),C3[RG6](N[RG6](C[RG6](O[NR])))))     &    ; Uracil H-C5
ATD  330    *   1   *   *   *   * (C[RG6,AR1.AR2.AR3](N[RG6](C(O[NR],N[RG6])),C3[RG6](C[RG6](O[NR]))))          &    ; Uracil H-C6
ATD  332    *   1   *   *   *   * (C4(C[RG6,AR1.AR2.AR3](C[RG6](O[NR],N[RG6]),C3[RG6](N[RG6](C[RG6](O[NR])))))) &    ; Thymine H-CC5
ATD  344    *   1   *   *   *   *          (C[RG6](C[RG6](C[RG6](N[NR],N2[RG6])),N[RG6](C[RG6](O1))))  &    ; Cytosine H-C5
ATD  372    *   1   *   *   1   *                (C4(N[RG5](C[RG5,RG6](N2)),C[RG5](N2(C[RG5,RG6]))))   &    ; 9-Me Adenine or Guanine H-CN9
ATD  374    *   1   *   *   1   * (C4(N[RG6,AR1.AR2.AR3](C[RG6](O[NR],N[RG6](C[RG6](O[NR]))),C[RG6](C[RG6]))))  &    ; 1-Me Uracil or Thymine H-CN1
ATD  376    *   1   *   *   1   *      (C4(N[RG6](C[RG6](O1,N2[RG6](C[RG6](N[NR]))),C[RG6](C[RG6]))))  &    ; 1-Me Cytosine H-CN1
ATD  392    *   1   *   *   1   *      (C4(N[RG6](C[RG6](O1,N3[RG6](C[RG6](N[NR]))),C[RG6](C[RG6]))))  &    ; 1-Me CytH+ H-CN1
ATD  416    *   1   *   *   *   *                      (C4(S[MI]))                                     &    ; H in CH3S-
ATD  419    *   1   *   *   *   *                      (C4(O[MI]))                                     &    ; H in CH3O-
ATD  426    *   1   *   *   *   *                      (C4(N[MI](H)))                                  &    ; HC in CH3NH-  RNH-
ATD  422    *   1   *   *   *   *                      (C4(N[MI]))                                     &    ; H in CH2CN-
ATD  430    *   1   *   *   *   *                      (C[MI])                                         &    ; H in CH3CH2-
ATD  432    *   1   *   *   *   *                      (C(C[MI]))                                      &    ; H1 in CH3CH2-
ATD  469    *   1   *   *   *   *                      (C[NR](O[NR](C3(O1))))                          &    ; methoxy Hs in esters
ATD  477    *   1   *   *   *   *                      (C4(S(N3,O1,O1)))                               &    ; H of Me attached to S of sulfonamide
ATD  485    *   1   *   *   *   *                      (C4(N3(S(O1,O1)),XX))                           &    ; H of alpha CH2-N of sulfonamide
ATD  483    *   1   *   *   *   *                      (C4(N3(S(O1,O1))))                              &    ; H of alpha CH3-N of sulfonamide
ATD  487    *   1   *   *   *   *                      (C4(C4(N3(S(O1,O1)))))                          &    ; H of beta CH3 of N-ethyl sulfonamide
ATD  702    *   1   *   *   *   *                      (C(C[PL](C,C)))                                 &    ; H in t-butyl+
//ATD  710    *   1   &    ; H in Cl..CH3..Cl- TS
ATD  759    *   1   *   *   *   *                      (C4(C2(N1)))                                    &    ; HC-CT-CN alpha-H in nitriles
ATD  763    *   1   *   *   *   *                      (C(C4(N(O,O))))                                 &    ; HC-CT-NO2 alpha-H in nitroalkanes
ATD  777    *   1   *   *   *   *                (C4[RG5](C4[RG5](C4[NR],O[RG5](C3[RG5](O1))),O[RG5])) &    ; propylene carbonate H in CH2
ATD  778    *   1   *   *   *   *                 (C4[RG5](C4[NR],C4[RG5](O[RG5]),O[RG5](C[RG5](O1)))) &    ; propylene carbonate H in CH
ATD  779    *   1   *   *   *   *                (C4[NR](C4[RG5](C4[RG5](O[RG5]),O[RG5](C[RG5](O1))))) &    ; propylene carbonate H in CH3
ATD  784    *   1   *   *   *   *                      (C(P[PL]))                                      &    ; H in CH3PR3+
ATD  140    *   1   *   *   *   *                      (C4(N3,C(O1,N)))                                &    ; alkane H.
ATD  140    *   1   *   *   *   *                      (C4(N4,C(O1,N)))                                &    ; alkane H.
ATD  140    *   1   *   *   *   *                      (C4(N3(C(O1,C4))))                              &    ; alkane H.
ATD  911    *   1   *   *   1   *                      (C(N3(H,H)))                                    &    ; H(C) for C bonded to N in amines, diamines (aziridine H2,H3)
ATD  926    *   1   *   *   *   *                      (C2[tb])                                        &    ; alkyne RC%CH terminal H
ATD  930    *   1   *   *   *   *                      (C4(C2[tb]))                                    &    ; alkyne RC%CH H on C3 (for C3 use #135-#139)
ATD  950    *   1   *   *   *   *                      (C4(N4,C(O1,O)))                                &    ; glycine zwit. 6-31G* CHELPG charges
ATD  958    *   1   *   *   *   *                      (C4(C,F,H))                                     &    ; H in RCHF in monoalkyl fluorides (tentative)
ATD  140    *   1   *   *   *   *                      (C4)                                            &    ; alkane H.
ATD  144    *   1   *   *   *   *                      (C3(C3[DB']))                                   &    ; alkene H (H-C=)

//HA types
ATD  316    *   1   1   *   *   * (C[RG6,AR1.AR2.AR3](C3[RG6](N[NR],N[RG6](C3[RG6](N[NR],C3[RG6]))),C3[RG6])) &    ; DAP H3
ATD  318    *   1   1   *   *   * (C[RG6,AR1.AR2.AR3](C3[RG6](C3[RG6](N[NR])),C3[RG6](C3[RG6](N[RG6],N[NR])))) &    ; DAP H4
ATD  597    *   1   1   *   *   *           (C[RG5,AR1.AR2.AR3](C3[RG5](C[RG5,RG6]),N3[RG5]))          &    ; H2 in indole
ATD  598    *   1   1   *   *   *           (C[RG5,AR1.AR2.AR3](C3[RG5](N3(C[RG5,RG6])),C[RG5,RG6]))   &    ; H3 in indole
ATD  599    *   1   1   *   *   * (C[RG6,AR1](C[RG6](C[RG6](C[RG6](C[RG5,RG6](N[RG5])))),C[RG5,RG6](C3[RG5](C3[RG5])))) &    ; H4 in indole
ATD  600    *   1   1   *   *   * (C[RG6,AR1](C[RG6](C[RG6](C[RG5,RG6](N[RG5]))),C[RG6](C[RG5,RG6](C3[RG5](C3[RG5]))))) &    ; H5 in indole
ATD  601    *   1   1   *   *   * (C[RG6,AR1](C[RG6](C[RG5,RG6](N[RG5])),C[RG6](C[RG6](C[RG5,RG6](C3[RG5](C3[RG5])))))) &    ; H6 in indole
ATD  602    *   1   1   *   *   * (C[RG6,AR1](C[RG5,RG6](N[RG5]),C[RG6](C[RG6](C[RG6](C[RG5,RG6](C3[RG5](C3[RG5]))))))) &    ; H7 in indole
ATD  389    *   1   1   *   1   *        (C[RG6,AR1.AR2.AR3](C[RG6](C[RG6](N[NR],N3[RG6])),N[RG6](C[RG6](O1)))) &    ; CytH+ H-C5
ATD  524    *   1   1   *   *   *     (C3[RG6,AR1.AR2.AR3](N[RG6](C3[RG6](C3[RG6])),C3[RG6](C3[RG6]))) &    ; H1 in pyridine 520-619
ATD  525    *   1   1   *   *   *     (C3[RG6,AR1.AR2.AR3](C3[RG6](N[RG6](C3[RG6])),C3[RG6](C3[RG6]))) &    ; H2 in pyridine
ATD  526    *   1   1   *   *   *     (C3[RG6,AR1.AR2.AR3](C3[RG6](C3[RG6](N[RG6])),C3[RG6](C3[RG6]))) &    ; H3 in pyridine
ATD  529    *   1   1   *   *   *                      (C3[RG6,AR1.AR2.AR3](N[RG6]),C3[RG6](N[RG6]))   &    ; H in pyrazine
ATD  534    *   1   1   *   *   *          (C[RG6,AR1.AR2.AR3](N[RG6](C[RG6]),N[RG6](C[RG6](C[RG6])))) &    ; H2 in pyrimidine
ATD  535    *   1   1   *   *   *          (C[RG6,AR1.AR2.AR3](N[RG6](C[RG6](N[RG6])),C[RG6](C[RG6]))) &    ; H4 in pyrimidine
ATD  536    *   1   1   *   *   *          (C[RG6,AR1.AR2.AR3](C[RG6](N[RG6](C[RG6])),C[RG6](N[RG6]))) &    ; H5 in pyrimidine
ATD  540    *   1   1   *   *   *     (C3[RG6,AR1.AR2.AR3](N[RG6](C3[RG6]),C3[RG6](C3[RG6](C3[RG6])))) &    ; H3 in pyridazine
ATD  541    *   1   1   *   *   *     (C3[RG6,AR1.AR2.AR3](C3[RG6](N[RG6](N[RG6])),C3[RG6](C3[RG6])))  &    ; H4 in pyridazine
ATD  546    *   1   1   *   *   *          (C[RG5,AR1.AR2.AR3](N[RG5](C3[RG5]),C3[RG5](C3[RG5])))      &    ; H2 in pyrrole
ATD  547    *   1   1   *   *   *          (C[RG5,AR1.AR2.AR3](C3[RG5](N[RG5](C3[RG5])),C3[RG5]))      &    ; H3 in pyrrole
ATD  554    *   1   1   *   *   *           (C[RG5,AR1.AR2.AR3](N[RG5](N3[RG5](C3[RG5])),C3[RG5]))     &    ; H3 in pyrazole
ATD  555    *   1   1   *   *   *           (C[RG5,AR1.AR2.AR3](C3[RG5](N3[RG5]),C3[RG5](N[RG5])))     &    ; H4 in pyrazole
ATD  556    *   1   1   *   *   *           (C[RG5,AR1.AR2.AR3](C3[RG5],N3[RG5](N[RG5](C3[RG5]))))     &    ; H5 in pyrazole
ATD  563    *   1   1   *   *   *           (C[RG5,AR1.AR2.AR3](N[RG5](C3[RG5]),N3[RG5](C3[RG5])))     &    ; H2 in imidazole
ATD  564    *   1   1   *   *   *           (C[RG5,AR1.AR2.AR3](C3[RG5](N3[RG5](C3[RG5])),N[RG5]))     &    ; H4 in imidazole
ATD  565    *   1   1   *   *   *           (C[RG5,AR1.AR2.AR3](N3[RG5](C3[RG5]),C3[RG5](N[RG5])))     &    ; H5 in imidazole
ATD  569    *   1   1   *   *   *           (C[RG5,AR1.AR2.AR3](XA2[RG5](C3[RG5]),C3[RG5](C3[RG5])))   &    ; H2 in furan
ATD  570    *   1   1   *   *   *           (C[RG5,AR1.AR2.AR3](C3[RG5](XA2[RG5](C3[RG5])),C3[RG5]))   &    ; H3 in furan
ATD  576    *   1   1   *   *   *           (C[RG5,AR1.AR2.AR3](N[RG5](C3[RG5]),O[RG5](C3[RG5])))      &    ; H2 in oxazole
ATD  577    *   1   1   *   *   *           (C[RG5,AR1.AR2.AR3](C3[RG5](O[RG5](C3[RG5])),N[RG5]))      &    ; H4 in oxazole
ATD  578    *   1   1   *   *   *           (C[RG5,AR1.AR2.AR3](O[RG5](C3[RG5]),C3[RG5](N[RG5])))      &    ; H5 in oxazole
ATD  584    *   1   1   *   *   *           (C[RG5,AR1.AR2.AR3](N[RG5](O[RG5](C3[RG5])),C3[RG5]))      &    ; H3 in isoxazole
ATD  585    *   1   1   *   *   *           (C[RG5,AR1.AR2.AR3](C3[RG5](O[RG5]),C3[RG5](N[RG5])))      &    ; H4 in isoxazole
ATD  586    *   1   1   *   *   *           (C[RG5,AR1.AR2.AR3](C3[RG5],O[RG5](N[RG5](C3[RG5]))))      &    ; H5 in isoxazole
ATD  613    *   1   1   *   *   * (C[RG6,AR1.AR2.AR3](N[RG6](C[2RG6,AR1]),C3[RG6](C3[RG6](C[2RG6,AR1])))) &    ; H2 in quinoline
ATD  614    *   1   1   *   *   * (C[RG6,AR1.AR2.AR3](C3[RG6](N[RG6](C[2RG6,AR1])),C3[RG6](C[2RG6,AR1]))) &    ; H3 in quinoline
ATD  615    *   1   1   *   *   * (C[RG6,AR1.AR2.AR3](C[2RG6,AR1],C3[RG6](C3[RG6](N[RG6](C[2RG6,AR1]))))) &    ; H4 in quinoline
ATD  616    *   1   1   *   *   * (C[RG6,AR1](C[2RG6,AR1](C[2RG6,AR1](C[AR1],N[RG6]),C3[RG6]),C[AR1](C[AR1](C[AR1])))) &    ; H5 in quinoline
ATD  617    *   1   1   *   *   * (C[RG6,AR1](C[AR1](C[2RG6,AR1](C[2RG6,AR1](C[AR1],N[RG6]),C3[RG6])),C[AR1](C[AR1]))) &    ; H6 in quinoline
ATD  618    *   1   1   *   *   * (C[RG6,AR1](C[AR1](C[2RG6,AR1](N[RG6],C[2RG6,AR1](C[AR1],C3[RG6]))),C[AR1](C[AR1]))) &    ; H7 in quinoline
ATD  619    *   1   1   *   *   * (C[RG6,AR1](C[2RG6,AR1](N[RG6](C3[RG6]),C[2RG6,AR1](C[AR1],C3[RG6])),C[AR1](C[AR1]))) &    ; H8 in quinoline
ATD  629    *   1   1   *   *   *               (C[RG6,AR1.AR2.AR3](N,N(C[RG6](C[RG5,RG6](N[RG5])))))  &    ; H2 in purine
ATD  630    *   1   1   *   *   *               (C[RG6,AR1.AR2.AR3](N,C[RG6](C[RG5,RG6](N[RG5]))))     &    ; H6 in purine
ATD  631    *   1   1   *   *   *   (C[RG5,AR1.AR2.AR3](N(C[RG5,RG6](N[RG6])),N(C[RG5,RG6](C[RG6](N[RG6])))))       &    ; H8 in purine
ATD  638    *   1   1   *   *   *          (C3[RG5,AR1.AR2.AR3](N[RG5](C3[RG5]),S2[RG5](C3[RG5])))     &    ; H2 in thiazole
ATD  639    *   1   1   *   *   *          (C3[RG5,AR1.AR2.AR3](C3[RG5](S2[RG5](C3[RG5])),N[RG5]))     &    ; H4 in thiazole
ATD  640    *   1   1   *   *   *          (C3[RG5,AR1.AR2.AR3](S2[RG5](C3[RG5]),C3[RG5](N[RG5])))     &    ; H5 in thiazole
ATD  643    *   1   1   *   *   *              (C[RG6,AR1.AR2.AR3](N2(C3[RG6]),N2(C3[RG6](N2[RG6]))))  &    ; H in 1,3,5-triazine
ATD  653    *   1   1   *   *   * (C[RG6,AR1.AR2.AR3](N[RG6](C[2RG6](C[2RG6],C[2RG6](N[RG6],C[2RG6](C[RG6])))),C[RG6](C[RG6]))) &    ; H2,H9 in 1,10-phenanthroline
ATD  654    *   1   1   *   *   * (C[RG6,AR1.AR2.AR3](C[RG6](N[RG6](C[2RG6](C[2RG6],C[2RG6](N[RG6],C[2RG6](C[RG6]))))),C[RG6])) &    ; H3,H8 in 1,10-phenanthroline
ATD  655    *   1   1   *   *   * (C[RG6,AR1.AR2.AR3](C[2RG6](C[RG6](C[RG6]),C[2RG6](N[RG6],C[2RG6](N[RG6],C[2RG6]))),C[RG6](C[RG6]))) &    ; H4,H7 in 1,10-phenanthroline
ATD  656    *   1   1   *   *   * (C[RG6,AR1.AR2.AR3](C[2RG6](C[2RG6](N[RG6])),C[RG6](C[2RG6](C[2RG6](N[RG6]))))) &    ; H5,H6 in 1,10-phenanthroline
//ATD  715    *   1   1   *   *   *                        (XX[AR1.AR2.AR3])       &    ; H in C5H5- cyclopentadienyl anion
//ATD  717    *   1   1   *   *   *                        (XX[AR1.AR2.AR3])       &    ; H in C5H5  cyclopentadienyl radical
ATD  740    *   1   1   *   *   *            (C[RG6,AR1.AR2.AR3](C[RG6](C[RG6](C[NR](N3[NR],N[NR]))))) &    ; HD of Benzamidine
ATD  741    *   1   1   *   *   *                    (C[RG6,AR1.AR2.AR3](C[RG6](C[NR](N3[NR],N[NR])))) &    ; HE of Benzamidine
ATD  746    *   1   1   *   *   *    (C[RG6,AR1.AR2.AR3](C[RG6](C[RG6](C[RG6](C[NR](N3[NR],N[NR])))))) &    ; H-CG of Benzamidine
ATD  146    *   1   1   *   *   *                      (C[RG6,AR1.AR2.AR3])                            &    ; Benzene H - 12 site.
// HA    *   1   1   &


// Cation types
// Li+
ATD  404    *   3   *   &    ; Li+
ATD  406    *   3   *   &    ; Li+ JACS 106, 903 (1984)

// Na+
ATD  405    *  11   *   &    ; Na+ JACS 106, 903 (1984)
ATD  407    *  11   *   &    ; Na+    Aqvists cation

// Mg2+
ATD  411    *  12   *   &    ; Mg++

// K+
ATD  408    *  19   *   &    ; K+  parameters: JPC,94, 8021 (90)

// Ca2+
ATD  412    *  20   *   &    ; Ca++

// Rb+
ATD  409    *  37   *   &    ; Rb+ parameters: JPC,94, 8021 (90)

// Sr 2+
ATD  413    *  38   *   &    ; Sr++

// Cs+
ATD  410    *  55   *   &    ; Cs+

// Ba2+
ATD  414    *  56   *   &    ; Ba++

ATD  436    *  92   *   &    ; U in UO2+ J Mol Struct 366, 55 (96)
ATD  697    *  89   *   &    ; Ac+3 Actinide params - F. van Veggel, Chem Eur J 5, 90 (1999).
ATD  698    *  90   *   &    ; Th+4 Actinide params - F. van Veggel, Chem Eur J 5, 90 (1999).
ATD  699    *  95   *   &    ; Am+3 Actinide params - F. van Veggel, Chem Eur J 5, 90 (1999).
ATD  703    *  57   *   &    ; La+3 Lanthanide params - F. van Veggel, Chem Eur J 5, 90 (1999).
ATD  704    *  60   *   &    ; Nd+3 Lanthanide params - F. van Veggel, Chem Eur J 5, 90 (1999).
ATD  705    *  63   *   &    ; Eu+3 Lanthanide params - F. van Veggel, Chem Eur J 5, 90 (1999).
ATD  706    *  64   *   &    ; Gd+3
ATD  707    *  70   *   &    ; Yb+3 see also JPC-A 104, 7659 (2000)

; These ion atomtypes are NOT part of OPLS, but since they are
; needed for some proteins we have added them.
ATD  Cu2+   *  29   *   &    ; Copper. See Inorg. Chem. 40, 5223 (2001).
ATD  Fe2+   *  26   *   &    ; Iron(II)
ATD  Fe3+   *  26   *   &    ; Iron(III)
ATD  Zn2+   *  30   *   &    ; Zinc
ATD  Ar     *  18   *   &    ; Argon
; Added by DvdS 05/2005 copied from GROMACS force field. 
ATD  SI     *  14   *   &    ; Silicium in Glass etc.

// Fluorine types
// F types
ATD  164    *   9   1   &    ; F Trifluoroethanol
ATD  719    *   9   1   &    ; F fluorobenzene
ATD  721    *   9   1   &    ; F hexafluorobenzene
ATD  726    *   9   1   &    ; F trifluoromethylbenzene
ATD  728    *   9   1   &    ; F difluorobenzenes
ATD  786    *   9   1   &    ; F in PF6-
ATD  956    *   9   1   &    ; F in monoalkyl fluorides (tentative)
ATD  965    *   9   1   &    ; F: perfluoroalkanes

// F- types
ATD  400    *   9   0   &    ; F-  JACS 106, 903 (1984)

// Chlorine types
// Cl types
ATD  151    *  17   1   *   *   *                      (C4)                                            &    ; Cl in alkyl chlorides
ATD  226    *  17   1   *   *   *                      (C3[DB])                                        &    ; chloroalkene Cl (ClH-C=) - see also #398
ATD  264    *  17   1   *   *   *                      (C[AR1])                                        &    ; Cl     chlorobenzene

// Cl- types
ATD  401    *  17   0   &    ; Cl- JACS 106, 903 (1984)
ATD  709    *  17   0   &    ; Cl charges: JACS 117,2024 (95)

// Bromine types
// Br types
ATD  722    *  35   1   &    ; Br alkyl bromide (UA, but probably ok for AA)
ATD  730    *  35   1   &    ; Br bromobenzene

// Br- types
ATD  402    *  35   0   &    ; Br- JACS 107, 7793(1985)

// Iodine types
// I types
ATD  732    *  53   1   &    ; I iodobenzene - tentative

// I- types
ATD  403    *  53   0   &    ; I-  JACS 120, 5104(1998)


// Lone Pair and unidentified types
ATD  433    *   0   &    ; LP in  CH3CH2-
ATD  797    *   0   &    ; M TIP4F Water

--------------------------------------------------------------------------------------------
============================================================================================




============================================================================================
                     Field descriptions
============================================================================================
(1)  ATD, which stands for atom type definition, ATD should always in the first three columns 
(2)  Atom type name, can be letters or numbers   
(3)  Residue names, which means this description is only applied to atoms in special residues
(4)  Atomic number 
(5)  Number of attached atoms 
(6)  Number of attached hydrogen atoms
(7)  For hydrogen, number of the electron-withdrawal atoms connected to the atom that the 
     hydrogen attached
(8)  atomic property
(9)  Chemical enviornment definitions


============================================================================================
                     Specific symbols
============================================================================================
*  Ignore this field
&  End of defination 
.  "or" operation in the ring and aromaticity descriptions 


============================================================================================
                     Predefined words
============================================================================================
EW   Electron-withdrawing atom
AA   Amino acid residue
NA   Nucleic acid
BIO  AA + NA

AR1  Pure aromatic atom (benzene and pyridine)
AR2  Atom in a planar ring, usually the ring has two contigous single bonds
AR3  Atom in a planar ring, which has one or several double bonds formed between outside atoms
     and ring atoms
AR4  Atom other than AR1, AR2, AR3 and AR5. 
AR5  Pure aliphatic atom in a ring, which is made of sp3 carbon

RG   Ring (from 3-membered to nine-membered)
RG3  3-membered ring 
RG4  4-membered ring 
RG5  5-membered ring 
RG6  6-membered ring 
RG7  7-membered ring 
RG8  8-membered ring 
RG9  9-membered ring 
NR   non-ring atom 

SB   Single bond
DB   Double bond
TB   Triple bond
AB   Aromatic bond
sb   Single bond, including aromatic single
db   Double bond, including aromatic double
tb   Triple bond

PL   Positive formal charge
MI   Negative formal charge

'    Bond type (SB sb etc) followed by ' means the current atom forms this kind of bond with the 
     immediately precessor in a chain of atoms
     For example, (XD3[SB',db]) means the current atom XD3 has a double bond with the atom in 
     definition 
''   Bond type (SB sb etc) followed by '' means the current atom does not form this kind of bond 
     with the immediately precessor in a chain of atoms
============================================================================================
                     Miscellaneous
============================================================================================
1. maximum line length is 500 characters
2. no space in the atomic property string
3. no space in the chemical environment string 
4. no filed missing before &
5. the definition order is crucial, special atom types should defined before the more general 
   ones
6. Bonds in COO- and -NO2 are considered as double bonds
